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Bone grafts are the second most transplanted tissue in the human body for the 
treatment of critical size bone defects. Despite the use of autografts, allografts and 
synthetic grafts, there is still a great demand for bone grafts. Bone tissue engineering 
has become a potential solution to these unmet clinical needs. In addition, biophysical 
stimulations have been shown to promote the development of bone grafts in vitro and 
in vivo. Tissue culture in bioreactor systems provides mechanical stimulation to the 
cell-seeded constructs. Application of pulsed electromagnetic field (PEMF) 
stimulation has been demonstrated to promote healing of non-union fractures in 
patients.  
 
The aim of this research was to investigate the effects of combining the 
aforementioned biophysical stimulations on the development of bone tissue engineered 
constructs. It was hypothesized that PEMF stimulation on MSCs results in improved 
ECM mineralization. It was also hypothesized that the combined stimulation would 
lead to a synergistic production of mineralized extracellular matrix (ECM), thereby 
producing a superior bone graft. 
 
For this purpose, a PEMF stimulation apparatus was built and characterized. 
Rabbit mesenchymal stem cells (MSC) were used as the cellular source and 
demonstrated to be able to differentiate into the osteogenic lineage. As a proof of 
concept, the cells were cultured in a flat well plate system and subjected to PEMF 
stimulation. The first hypothesis was proven and PEMF does exert a positive effect on 
MSCs which are differentiating down the osteogenic lineage. 
x 
 
In the second phase, a scaffold system was developed to provide a 3D 
environment for the cells. Bombyx mori silk was dissolved into solution, cast into a 
mold and freeze dried to form porous silk sponge scaffolds. The scaffold was found to 
be suitable for supporting bone tissue engineering. The 3D construct was then cultured 
in a static well plate and exposed to PEMF stimulation. Once again, PEMF stimulation 
resulted in greater production of calcium compared to the control group. 
 
In the third phase, a flow perfusion bioreactor was built to provide a dynamic 
culture system, as well as to overcome limitations of static seeding technique. The 
perfusion bioreactor also demonstrated its efficacy in supporting the development of 
cell-seeded constructs. Cell viability was maintained and there was greater deposition 
of calcium in the bioreactor constructs compared to static culture constructs. 
 
In the final phase, cell constructs were cultured in bioreactor chambers which 
were integrated with the PEMF apparatus. Control group samples were cultured in 
bioreactors without PEMF stimulation. There was no synergistic production of 
mineralized ECM as hypothesized. Both groups had approximately the same amount 
of calcium by the end of the study. However, an interesting finding was that the study 
group had significant amount of calcium deposition at week one, about twice of that 
formed in the control group.  
 
The findings suggested that combined stimulation could be used to accelerate 
bone formation in tissue engineered constructs, reducing the time required to culture 
bone grafts. Hence, there is potential application in using PEMF technology coupled 
with bioreactors to enhance the development of bone grafts. 
xi 
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1.1 Bone Biology 
1.1.1 Functions of bone and the skeletal system 
Bone is a remarkable organ that is responsible for several important functions 
in the body, which can be broadly divided into mechanical, synthetic and metabolic 
aspects. By definition, bone as an organ comprises of the bone tissue / osseous tissue, 
marrow, blood vessels, epithelium and nerves. On the other hand, bone tissue, also 
known as osseous tissue, is the mineralized connective tissue, which is formed by 
osteoblasts. These cells lay down a matrix of collagen type I, calcium, magnesium and 
phosphate ions that will eventually form a crystalline bone mineral known as 
hydroxyapatite. 
 
The main function of bone in the skeletal system is to provide mechanical 
support. As bone is rigid, strong and comes in different shapes, it provides a 
framework for structural support and offers protection to the vital body organs. Bone is 
capable of remodeling, which allows it to respond to changes in its mechanical 
environment to meet different loading demands, thereby maintaining an optimal 
balance between form and function [1]. Bone also functions together with skeletal 
muscles, tendons, ligaments and joints to generate forces that bring about body 




Bone is the primary location for the synthesis of blood cells. Erythrocytes, 
leukocytes, platelets and other blood cells are produced via haematopoiesis by the 
haemapoietic stem cells found within the medullary cavity of long bones and 
interstitial spaces of cancellous bones.  
 
The metabolic functions of bone are storage of minerals, growth factor and fat, 
acid-base balance, detoxification and as an endocrine organ. Minerals, especially 
calcium and phosphorus, are stored as reserves in bones. Important growth factors such 
as insulin-like growth factors, transforming growth factor, and bone morphogenetic 
proteins (BMP) are stored in the mineralized bone matrix. The yellow bone marrow 
serves as a storage reserve of fatty acids. Bone also helps to buffer and regulate the pH 
balance in the blood via the absorption or release of ionic salts. Heavy metals and other 
elements are removed from the blood and stored in bone tissues so as to lessen their 
toxic impact on other tissues. Last but not least, bone acts as an endocrine organ by 
releasing fibroblast growth factor-23, which acts on the kidneys to reduce phosphate 
resorption. 
 
1.1.2 Structure and Composition of Bone 
From a macro perspective, there are two types of bone structure, the compact 
(cortical) bone and the trabecular (cancellous) bone. Cortical bone forms the dense 
outer shell of most bones and it accounts for 80% of the total bone mass. Cortical bone 
is mostly found in the shaft portion of long bones and the outer shell found around the 
spongy bone at the end of joints. It is denser than cancellous bone and is characterized 
by few gaps and spaces, with porosity of 5 to 30% [2]. Therefore, it is also harder, 
stronger and stiffer than cancellous bone. On the other hand, cancellous bone consists 
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of a network of struts surrounding interconnected spaces. It is the spongy interior bone 
tissue which makes up 20% of the total bone mass. Cancellous bone is less dense, 
softer, weaker and less stiff, but has a higher surface area. Its porosity ranges from 50 
to 90% and is highly vascular, often containing bone marrow [2]. Microscopically, 
compact and cancellous bones are different in that compact bone consists of haversian 
sites and osteons while cancellous bone does not. Secondly, bone surrounds blood in 
compact bone while blood surrounds bone in the cancellous bone. 
 
On a microscopic level, the structure of bone can be distinguished into woven 
and lamellar bone based on the pattern of collagen forming the osteoid. Woven bone is 
immature bone, characterized by a disorganized collagen fibre arrangement with no 
orientation. Woven bones are found in fetal bones during embryonic skeletal 
development, initial fracture healing and in Paget’s disease. Woven bone forms 
quickly as the osteoblasts generate osteoid rapidly. It is weaker and will eventually be 
replaced by lamellar bone. In contrast, lamellar bone has a regular parallel alignment 
of collagen into sheets (lamellae). Lamellar bone starts to form around 1 month after 
birth. Woven bone is resorbed by 1 year of age and most normal bone is lamellar bone 
by age 4. Lamellar bone is anisotropic in nature due to the highly organized and stress-
oriented collagen. Depending on the orientation of applied forces, anisotropic 
properties affect the mechanical behaviour of lamellar bone. The bone is strongest in 
the direction parallel to the long axis of the collagen fibres. In the body, woven and 




Bone comprises of several components. They are the bone cells, organic and 
inorganic matrix. Table 1.1 below shows the percentage by volume that each of these 
components occupy as well as its constituents. 
 





Cellular elements (including osteoblasts, osteocytes, bone lining 
cells and osteoclasts 
5 to 10% 
Organic matrix (including collagen, proteoglycans and non-
collagenous proteins) 
20 to 40% 
Inorganic minerals (including hydroapatite) 50 to 70% 
Lipid 3% 
 
On a cellular level, there are three main types of bone cells, namely the 
osteoblasts, osteocytes and osteoclasts. Osteoblasts are the bone-forming cells that 
originate from the mesenchymal bone marrow stromal cells found in the deeper layer 
of periosteum and bone marrow. Morphological features reveal that it has a single 
large spherical nucleus and a basophilic cytoplasm, due to the presence of a large 
amount of rough endoplasmic reticulum. To become osteoblasts, mesenchymal stems 
cells must first differentiate into osteoprogenitor cells that express the master 
regulatory transcription factor Cbfa-1/Runx2. Once differentiated into osteoblasts, 
bone genetic markers such as alkaline phosphatase (ALP), bone sialoprotein (BSP), 
collagen type I (COL I), osteocalcin (OC), osteopontin (OSP) and osteonectin (ON) 
will be expressed. Osteoblasts form bone by laying down a matrix of osteoid made up 
of mainly collagen type I and the subsequent mineralization of the matrix. Osteoblasts 
are considered immature bone cells. The osteoblasts that are trapped in the bone matrix 
and remain isolated in lacunae will mature to become osteocytes.   
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Osteocytes are the most abundant cell found in bone. It is presented as a star 
shaped cell with a single nucleus and a thin ring of cytoplasm. Osteocytes reside in 
oblong spaces between the bone lamellae known as the lacunae and they possess long 
cytoplasmic extensions that are interconnected via gap junctions to other osteocytes 
and osteoblasts via the canaliculi. Osteocytes play a role in functions like bone 
formation, matrix maintenance, and calcium homeostasis. In addition, they have been 
shown to act as mechano-sensory receptors by regulating the bone’s response to stress 
and mechanical load. 
 
Osteoclasts are large, multinucleated cells which are located in resorption pits 
on bone surfaces. They are derived from monocytes/macrophages that originate from 
the haematopoietic stem cell lineage. Osteoclasts are the cells responsible for bone 
resorption, which is the process by which osteoclasts break down bone and release the 
minerals. Osteoclasts are distinguished by its high expression of tartrate resistant acid 
phosphatase (TRAP) and cathepsin K. 
 
On a molecular level, the bone matrix is composed of an organic and inorganic 
part. The organic part’s main component is collagen type I, which accounts for 
approximately 30% of the dry non-mineralized matrix. Collagen type I is a 
heteropolymer of two identical and one distinct chain, each having the primary 
structure (Gly-X-Y)n, where X and Y are frequently proline or hydroxyproline. 
Collagen type I provides a backbone for bone mineral deposition as bone mineral 
crystals are aligned with their long axis parallel to the collagen axis. Bone also 
contains small amounts of collagen type III, V and XII, which plays a role in 
regulating the diameter of the type I fibrils and may affect the properties of the tissue. 
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The organic matrix also contains growth factors like glycosaminoglycans, osteocalcin, 
osteonectin, bone sialoprotein and osteopontin.  
 
The inorganic part of bone is a major mineral storage, containing 99% of body 
calcium and 88% of body phosphate [4]. These minerals exist as hydroxyapatite 
(Ca10(PO4)6(OH)2) molecules, taking the form of spindle- or platelet-shaped crystals 
within the bone matrix. Other components include calcium carbonate, calcium fluoride 
and magnesium fluoride. Formation of the inorganic matrix begins with its deposition 
as un-mineralized osteoid by osteoblasts. Osteoblasts then secrete vesicles containing 
ALP, which cleaves the phosphate groups and acts as the foci for calcium and 
phosphate deposition. Rupturing of the vesicles provides a nucleus for crystallization 
of hydroxyapatite to occur. Hydroxyapatite provides the bone matrix with mechanical 
properties like high stiffness and load bearing capacity. 
 
1.2 Bone defects 
Bone is a dynamic and highly vascularised tissue which has the ability to heal 
and remodel without leaving a scar [5]. Bone can suffer from a wide range of disorders 
including delayed and non-union fractures, osteoporosis, congenital pseudarthroses 
and cancer among others. There is a limit to the size of bone fracture or defect that the 
body is able to restore to healthy tissues. Critical sized defect is unable to heal 
naturally by itself and requires bone graft implantation to achieve bone healing. In fact, 
bone graft is the second most transplanted tissue in the world just after blood [6]. A 
report by the US Bone Grafts market projects the demand for bone grafts to reach 
US$2.3 billion by 2017, driven by aging populations, rising incidences of degenerative 
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intervertebral disc diseases, rise in the number of revision orthopaedic surgeries and an 
increasing number of seniors seeking an active lifestyle [7].  
 
1.2.1 Bone Fracture Healing 
Bone fracture, if healed properly, results in the regeneration of the bone 
anatomy and complete restoration of function. This is unlike soft tissue healing which 
leads to scar formation. Fracture healing can be divided into primary (direct, cortical) 
and secondary (indirect, spontaneous) bone healing, both of which involve highly 
regulated series of biological events. Primary bone healing is less common because it 
requires rigid fixation of the fracture site. On the other hand, secondary healing via the 
formation of a callus tissue around the fracture site is more common. Secondary 
fracture healing can be divided into three main phases: the inflammatory, reparative 
and remodeling phase. These phases overlap one another, effectively forming a 
continuous healing process. 
 
Inflammatory phase 
Immediately after an injury, an inflammatory response is elicited, peaks in 48 
hours and disappears almost completely by 1 week post fracture. The purpose of this 
inflammatory response is to help immobilize the fracture by causing pain, which 
causes the individual to protect the injury; and swelling hydrostatically to prevent the 
fracture from moving. At the site of injury, vascular endothelial damage leads to the 
initiation of the complement cascade, platelet aggregation and release of its α-granule 
contents. Hematoma accumulates within the medullary canal between the fracture ends 
and beneath elevated periosteum and muscle. Its formation serves as (1) a haemostatic 
plug to limit further hemorrhage (2) a fibrin network that provides pathways for 
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cellular migration and (3) a source of signaling molecules that initiate cellular events 
essential to fracture healing. The process leads to a reparative granuloma known as an 










Figure 1.1: Schematic representation of the three stages of fracture repair. (Reproduced 
from Lieberman, 2005) 
 
Reparative phase 
The result of this phase will be the development of a reparative callus tissue in 
and around the fracture site and this will in due course be replaced by bone. Callus 
plays the role of enhancing mechanical stability by supporting it laterally. Necrotic 
tissue and debris are resorbed by phagocytes and osteoclasts. Multipotent 
Reparative phase (Fibrocartilage 
Callus Formation) – Fibrous tissue 
and new cartilage are beginning to 
form and revascularization is 
taking place.  
Inflammatory phase – Vascular 
endothelial damage results in 
formation of hematoma. 
Complement and clotting cascade 
leads to the activation of cells 
responsible for bone repair 
Remodeling phase – Replacement of 
woven bone by lamellar bone and the 
resorption of excess callus. Gradual 
modification of the fracture region 
leads to restoration of normal bone 
architecture 
Reparative phase (Bony Callus 
Formation) – Intramembranous 
and endochondral ossification is 




mesenchymal stem cells are believed to play an important role during the reparative 
phase. In the external area of the callus tissue (hard callus) where there is adequate 
blood supply, MSCs will differentiate into osteoblasts, which then form the woven 
bone through intramembranous ossification. In other areas where the vascularization is 
inadequate, MSCs will differentiate into chondroblasts and produce the avascular 
basophilic cartilage matrix. This region of fibrous tissue and cartilage is known as the 
soft callus and eventually all the fibrous tissue will be replaced by cartilage. As 
fracture healing progresses, there will be abundant cartilage overlying the fracture site 
and calcification occurs by the process of endochondral ossification. The callus 
calcifies and becomes more rigid and the fracture site is considered internally 
immobilized. Capillaries from adjoining bones grow into the calcified cartilage, 
increasing the oxygen tension. This is followed by the invasion of osteoblasts, which 
forms the primary spongiosa consisting of both cartilage and woven bone. Eventually 
the callus is composed of only woven bone which connects the two fracture ends and 
remodeling process begins [8]. 
 
Remodeling phase 
 The remodeling phase is the last phase in fracture healing and starts with the 
replacement of woven bone by lamellar bone and the resorption of excess callus. After 
all the woven bone has been replaced, the remodeling will involve osteoclastic 
resorption of poorly located trabeculae and formation of new bone along lines of stress. 
The outcome of remodeling phase is a gradual modification of the fracture region 
under the influence of mechanical loads until optimal stability is achieved, and the 




1.3 Current treatment and limitations 
There are three types of bone grafts which are available for treating bone 
defects: autografts, allografts and synthetic grafts.  
Autograft is the gold standard of bone grafting and it involves harvesting bone 
from the patient’s own body. Autograft bones possess optimal osteoconductive, 
osteoinductive and osteogenic properties which could promote bone regeneration at the 
defect site. The most common donor site for autograft is the iliac crest as it provides 
easy access to good quality and quantity cancellous bone. Problems associated with 
harvesting of autologous bone are: lengthening of overall surgical procedure, residual 
pain and cosmetic disadvantages, complications like haematoma, blood loss, nerve 
injury, hernia formation, infection and chronic pain at donor site [6].  
 
Allograft bone is derived from humans and is harvested from an individual 
other than the one receiving the graft. It is frequently being used by surgeons, 
accounting for a third of bone grafts performed in the United States [6] and is possible 
to customize the allograft tissue into different shapes and sizes. Drawbacks associated 
with allografts include immunogenic reactions, risk of disease transmission and 
diminished osteointegration properties due to the processing methods. 
 
Synthetic grafts are bone graft alternatives that are made from ceramics or 
metals. Ideally, a bone graft substitute should be osteoconductive, osteoinductive, 
biocompatible, bioresorbable, structurally similar to bone, easy to use and cost 
effective [6]. Among the bone graft alternatives available in the commercial market, all 
of them vary in composition, mechanism of action and special characteristics. Most of 
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them are osteoconductive, offers varying degrees of structural support and have very 
limited ability for osteoinduction.     
 
 Bone grafts, being the second most commonly implanted tissue, are in high 
demand for a wide range of orthopaedic clinical problems. As shown from the 
preceding paragraphs, fresh autogenous bone is the gold standard graft material which 
other substitutes should benchmark against. Currently available bone graft substitutes 
have their own advantages and drawbacks. However, none of them are able to 
encompass the three essential elements of bone regeneration of osteogenesis, 
osteoinduction and osteoconduction. With the advance in tissue engineering, new 
scaffold constructs are continually being designed to have more biomimetic 
architectures and to have the ability to incorporate growth factors and mesenchymal 
stem cells. These tissue engineered constructs will, in due time, be able to cope with 
the demand for bone grafts. 
  
1.3.1 Bone tissue engineering  
Bone tissue engineering is an interdisciplinary field that applies the principles 
of engineering and life sciences towards the development of viable substitutes that 
restore and maintain the function of human bone tissues. Bone tissue engineering 
involves the following key ingredients: (1) identifying and harvesting suitable cell 
sources, (2) three dimensional (3D) matrices, (3) suitable tissue culture system and (4) 
biomolecules such as angiogenic factors, growth factors and differentiation factors. 
From these ingredients, there are three main approaches to develop a biological bone 
graft substitute [9-11]: (A) using a scaffold alone that will support tissue regeneration 
by the host tissue; (B) using a cell-seeded scaffold construct to enhance the osteogenic 
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potential of the scaffold; (C) using a scaffold loaded with growth factor(s) to deliver 
osteoinductive factors. Through these bone tissue engineering techniques, issues such 
as bone graft shortage, suitable donors, long term dependence on immune-suppression 
drugs and the risk of disease transmission could be overcome. 
 
1.3.2 Biophysical stimulation – alternative options for bone healing  
Biophysical stimulation methods have been developed and used to stimulate 
bone regeneration during fracture healing. Two methods of biophysical stimulation are 
currently being used, namely pulsed electromagnetic field (PEMF) and low intensity 
pulsed ultrasounds (LIPUS). These methods represent a generally non-invasive, safe 
approach and there are many studies which confirm their beneficial effects. Three 
different methods of electric field (EF)/electromagnetic fields (EMF) are approved for 
use by the FDA in the United States: capacitive coupling using electrodes placed on 
the skin, direct current stimulation using implanted electrodes, and electromagnetic 
stimulation by inductive coupling using time varying magnetic fields. In the 
electromagnetic field modality, there are two different technologies currently FDA-
approved for clinical applications: pulsed electromagnetic fields (PEMF) and 
combined magnetic fields (CMF) [12]. Ultrasound (US) was approved by FDA in 
1994 in the United States for treatment of fresh fracture healing, and nonunion/delayed 
union healing was approved in 2000 [12]. However, while it is clear that both EMF 
and US stimulations have a clinically significant effect on bone repair, the exact 
mechanism of why they accelerate bone healing is still not clear. Hence, the author is 
interested in studying the effects of such biophysical stimulation on bone formation 








2.1 Bone tissue engineering strategy 
 To regenerate new bone, biological issues like cells, extracellular matrix, 
intercellular communications, cell-to-matrix interactions and growth factors need to be 
factored into consideration. In addition, bone has a 3D configuration and cells need to 
be grown in a scaffold which can provide a 3D environment. The general approach to 
bone tissue engineering revolves around several components, namely cells, scaffolds, 
growth factors and culture systems (2D culture plates, bioreactors and animal models). 
Bone tissue engineering strategies may employ two or more of these components in 
various combinations, but an appropriate 3D scaffold remains the essential component 
for successful regeneration of bone tissue.  
 
Generally, there are three main strategies in bone tissue engineering. The first 
involves using only the scaffold and is typically used in conjunction with the animal 
model. The scaffold is implanted into the defect site to support the tissue regeneration 
by the host tissue. Cells from the surrounding host tissue will migrate into the scaffold 
and regenerate the bone tissue over time. The scaffold should be able to provide spatial 
and temporal cues to facilitate the tissue regeneration [13]. Spatial cues include the 
porosity, which affects the mass transport capabilities of the scaffold; mechanical 
strength, which affects the load bearing and regulating cell behaviour via 
mechanotransduction signaling; surface topography, which affects cell morphology, 
activities and autocrine/paracrine regulatory factor production [14]; and structural 
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properties, which guide cell and ECM orientation. Temporal cues refer to the 
degradation rate of the scaffold. Tuning the degradation rate of scaffolds to the 
development of regenerated bone tissue enables the defect site to be fully taken over 
by the functional tissue in a timely manner [13].  
  
The second approach involves using the scaffold as a growth factor/drug 
delivery vehicle. This strategy loads scaffolds with growth factors like BMP-2 such 
that upon implantation, cells from the body are recruited to the scaffold site and 
regenerate bone tissue. Factors like BMPs, transforming growth factor beta (TGF-β), 
fibroblast growth factor (FGFs), insulin growth factor I and II (IGF I/II) and platelet 
derived growth factors (PDGF) are common ones which have been proposed for bone 
tissue engineering applications [15]. Through the use of a local controlled release 
system, osteoinductive factors could provide temporal cues at desired therapeutic 
concentrations over an appropriate duration. This could prevent the factors from being 
depleted too quickly and also limit side effects at unwanted body locations. 
 
The third strategy involves the use of scaffolds as a cell support device. Cells 
are seeded into the scaffolds in vitro where they are encouraged to lay down ECM to 
create the foundations of a tissue for transplantation [16]. In this strategy the scaffold 
properties and the culture system play a particularly important role. Once the scaffold 
is seeded with cells, the solute diffusion and distribution patterns are greatly influenced 
by the cell organization. In vivo, metabolically active cells are mostly situated within 
100µm from a capillary [17, 18]. Therefore, for this strategy to be successful, the 
scaffold must have a suitable pore size, porosity, pore interconnectivity and surface 
area. This is to facilitate the mass transport of nutrients and wastes in vitro and 
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subsequent vascularization after transplantation. A bioreactor should be used for the in 
vitro culture system to enable perfusion of medium into the central parts of the 
scaffolds. Besides using cells and scaffolds, strategy III can also utilize growth factor 
loaded scaffolds in strategy II to enhance the development of the tissue. 
 
For the scope of this project, studies will be done in-vitro only. Hence, 
components like cells, scaffolds and bioreactor systems will be used. These will be 
discussed in subsequent sections of this chapter. 
 
2.2 Cellular sources for bone tissue engineering 
2.2.1 Cell sources used for bone tissue engineering 
A reliable cell source in bone tissue engineering should be easily isolated and 
expanded into high numbers. Ideally, it should allow expansion to higher passages, 
non immunogenic, and have a protein expression pattern similar to the tissue to be 
regenerated [19]. Cells used in cell-based approach to bone tissue engineering can be 
harvested from two key sources, namely differentiated bone tissue and non-bony 
tissues containing mesenchymal stem cells (MSCs). Such tissues include bone marrow 
as well as other connective tissues [13]. 
 
Differentiated osteoblasts 
Osteoblasts are differentiated bone cells that are responsible for bone formation 
by laying down a matrix of osteoid made up of mainly collagen type I and the 
subsequent mineralization of the matrix. Osteoblasts has been extensively used as a 
cellular source for bone tissue engineering applications and was shown to result in 
improvement in the rate of bone regeneration over undifferentiated bone marrow [20-
16 
 
22]. The drawback of using osteoblasts is that the harvesting of osteoblasts from the 
body is harder and more complicated as compared to fresh bone marrow or MSCs. 
There is also limited proliferative capacity and hence difficult to expand in vitro to get 
a clinically significant number of cells for use in various applications [21-23]. 
 
Mesenchymal Stem Cell (MSC) 
 Bone marrow was the first tissue described as a source of plastic-adherent, 
fibroblast-like cells that develops colony-forming units (CFU-Fs) when plated in tissue 
culture plates [24]. Mesenchymal stem cells are multipotent stem cells that can 
differentiate into a variety of cell types, such as osteoblasts, chondrocytes and 
adipocytes. This multipotency has been demonstrated in studies using both in vitro and 
in vivo models [25]. MSCs are rare in bone marrow, representing 1 in 10,000 
nucleated cells. While they are not immortal, they are able to expand multi folds in 
culture and still retain their growth and multilineage potential. Morphologically, MSCs 
are characterized by a small cell body with a few long and thin cell processes.  
 
 The properties of MSCs make it a potentially ideal candidate for tissue 
engineering. MSCs are relatively easy to isolate due to their adherence to plastic and 
they can be easily expanded in culture for various applications. The methods for 
inducing the MSCs into the osteogenic lineage are also well established in literature. 
Studies have also demonstrated that MSCs possess immunomodulatory properties 
which enable them to avoid allorecognition, interfere with dendritic cell and T-cell 
function, and generate a local immunosuppressive microenvironment by secreting 
cytokines [26]. Hence, they are able to avoid allogeneic rejection in humans and 
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animal models. Other studies have also shown MSCs are able to retain their osteogenic 
potential even after long term cryopreservation [27]. 
 
MSCs are fibroblast-like cells that form colonies during their initial growth in 
vitro. There are no specific cell markers to identify MSCs from other cell types. 
According to the Mesenchymal and Tissue Stem Cell Committee of the International 
Society for Cellular Therapy, the minimum criteria to define human MSCs are [28]:  
(1) MSC must be plastic adherent. 
(2) Must express CD105, CD73 and CD90.  
(3) Lack expression of CD14, CD34, CD45 and CD11b, CD79a, CD19 and HLA-DR 
surface molecules.  
(4) Demonstrate multi-potency: must differentiate into osteoblasts, chondrocytes and 
adipocytes in vitro. 
(5) Lack expression of hematopoietic antigen. 
 
2.2.2 Sources of MSCs 
MSCs are multipotent cells which can be derived from both marrow and non-
marrow tissues. Bone marrow derived MSCs are the most widely studied and 
established among the MSC sources. Besides bone marrow derived MSCs, 
improvements in cell isolation technology has made it possible to isolate and identify 
MSCs from other sources. For example, the youngest and most primitive MSCs can be 
found in the umbilical cord tissue, specifically Wharton’s jelly and the umbilical cord 
blood. Wharton’s jelly has a higher concentration of MSCs compared to the umbilical 
cord blood, which has more hematopoietic stem cells. Other adult tissue sources 
include the synovium, periosteum, skeletal muscles, and adipose tissue [29]. Among 
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all the sources, bone marrow mesenchymal stem cells are the most well characterized 
MSCs. Therefore, it would be most apt to use it to study the effects of EMF 
stimulation.  
 
2.3 Scaffolds for Bone Tissue Engineering 
2.3.1 Functions of scaffolds 
Scaffold is an important component in bone tissue engineering. This is because 
bone is 3D in structure and a suitable scaffold would be able to mimic this 3D 
environment for cells to grow into. A scaffold is also important for the following 
reasons. It will serve as a temporary matrix for cell proliferation and extra-cellular 
deposition. It will allow bone in-growth until the new bony tissue is fully restored / 
regenerated. It provides cells with a tissue specific environment and architecture, hence 
providing environment and topological cues for growing towards the targeted lineage. 
It acts as a store of water, nutrients, cytokines and growth factors. It could also act as a 
template for vascularization to occur [5]. 
 
2.3.2 Specifications for bone tissue engineering scaffolds 
In view of the importance of scaffolds listed above, it is essential that the 
scaffold used in bone tissue engineering possess the right set of properties for its 
intended purpose. These properties are going to affect the cell survival, signaling, 
growth, propagation, and reorganization, as well as their gene expression and the 
preservation of phenotypes. The following properties are the key ones which have 
been mentioned widely in most literature. 
(1) Biocompatibility: The scaffolds should be well integrated in the host’s tissue 
without causing an immune response. 
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(2) Pore size: Adequate pore size is required for nutrient permeation, cellular 
migration and vascularisation in vivo.  Pore sizes that are too small will lead to 
occlusion by the cells and its deposited extracellular matrix (ECM). It will also 
impede cellular penetration, ECM production and neovascularization of the 
scaffold interior. On the other hand, pores that are too large may result in the cells 
falling off the biomaterial surface. For bone tissue engineering, the preferred pore 
size ranges from 100μm to 500μm for in vitro culture [30]. However, several 
sources have suggested that pore sizes ranging between 500μm to 900μm are also 
feasible for bone tissue engineering [5]. Considering vascularisation to be the only 
phenomena leading to adequate mass transport within the thick engineered tissue in 
vivo, the minimum pore size should be 300μm [31]. Henceforth, the pore size 
range for this project is chosen to be about 300μm or slightly larger.  
(3) Porosity:  High porosity and interconnectivity are desirable for cellular in-growth 
and an even distribution of cells throughout the scaffold structure. It is also 
important for the diffusion of nutrients and gases and the removal of metabolic 
waste from the cells growing within the scaffold. The degree of porosity of a 
scaffold also affects other scaffold properties especially its mechanical properties. 
Therefore for bone tissue engineering, where mechanical needs of the tissue to be 
replaced are a concern, the porosity would need to be balanced with the mechanical 
strength of the scaffold. A porosity of at least 70% has been established in the 
literature.   
(4) Interconnected porous network.  This is required for cellular migration and nutrient 
and metabolite transport. 
(5) Adequate mechanical strength: There are different requirements for scaffolds used 
in vitro and in vivo studies. For in vivo studies, the scaffold obviously has to have 
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mechanical properties that are able to match the native bone tissue at the site of 
implantation. This will allow the scaffold to provide sufficient temporary 
mechanical support to tolerate in-vivo stresses and load bearing.  For in-vitro 
studies, the scaffold mechanical properties should be adequate to withstand the 
hydrostatic pressure and maintain the architectural integrity of the scaffold, 
especially the spaces within the pores that are important for cell in-growth and 
ECM production. 
(6) Biodegradability.  The degradation rate should be tuned to match the formation of 
the tissue.  Ideally the strength of the scaffold should be retained until the tissue 
engineered construct is fully remodelled by the host tissue and take over its 
structural role. Too low a degradation rate impedes tissue formation and too high a 
degradation leads to inadequate material for ECM deposition.     
 
2.3.3 Selection of materials for scaffolds 
The materials used for scaffolds serve the following functions: (1) to provide 
the overall shape to the construct in order to facilitate the generation of a useful size 
and volume of tissue, (2) to facilitate the delivery of signals, both molecular and 
mechanical to the cells, and (3) to support the cells and optimize their function within 
the scaffold. To date, there have been many attempts at engineering a bone tissue for in 
vivo applications by using various biomaterials for scaffold fabrication. Some 
examples are silk, bioceramics e.g. hydroxyapatite and tricalcium phosphate, the 
family of poly (α-hydroxy) esters e.g. PLGA.  The advantages and possible drawbacks 






Bioceramics are inorganic and non-metallic materials that can assume a 
crystalline structure. Examples of ceramics based materials include calcium 
phosphates, calcium sulfates and bioactive glass. These materials, particularly the 
calcium phosphates, have been widely used as scaffolds for bone healing because the 
inorganic matrix of bone is essentially made up of the ceramic calcium hydroxyapatite. 
Bioceramics are biocompatible materials which are hard and brittle. It possesses good 
compressive strength but poor tensile properties.  It also has high resistance to wear 
and low frictional properties in articulation. These properties make it a good candidate 
for hard and soft tissue replacement applications. Bioceramics are used in many types 
of medical applications with bone and dental implants being the most common. The 
main drawback of using ceramics is their inherent brittleness, which makes them prone 
to micro-cracks. Modern technology and fabrication techniques have helped to 
overcome some but not all of these problems.  
 
2.3.3.2 Polymers 
A polymer is a large macromolecule made up of repeating structural units 
connected via covalent bonds. It can occur naturally or be synthesized in the laboratory. 
Naturally occurring polymers come from living organisms and are usually purified and 
processed before it can be considered suitable for biomedical usage. Examples of 
natural polymers include alginate, chitosan, collagen, gelatin and hyaluronic acid. 
Synthetic polymers are fabricated via chemical processes and are typically 
biodegradable. Synthetic polymers are usually able to overcome problems faced by 
natural polymers, such as shortage of sources, cost of purification, inter-batch variation 
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and cross contamination. Synthetic polymers are also more customizable for specific 
mechanical and physicochemical properties.  
 
2.3.3.3 Silk  
Silks are naturally occurring protein polymers that are produced in fibrous form 
by silkworms and spiders. Silk produced by the Bombyx mori (B. Mori) silkworm has 
a long history of successful application in medicine as suture material. Hence, it has 
great potential as a biomaterial. In its natural form, silk is made up of two main 
proteins, a filament core of silk fibroin, and a glue-like coating known as sericin. The 
silk fibroin fibers measure about 10 to 25μm in diameter and consist of two proteins: a 
light chain (~26kDa) and a heavy chain (~390kDa) present in a 1:1 ratio and linked via 
a single disulfide bond. The disulfide linkage that holds the fibroin together is between 
the Cys-c20 (20th residue from the carboxyl terminus) of the heavy chain and Cys-172 
of the light chain and a 25kDa glycoprotein P25 is non-covalently linked to these 
proteins. These fibroins are coated with sericin (30 to 310kDa), which belongs to a 
family of hydrophilic proteins. Sericin, which makes up 25 to 30% of the silk cocoon 
mass, is removed from the silk fibroin by boiling the raw silk in an alkaline solution. 
Sericin has been shown to cause an adverse immune response after implantation in the 
human body, thus the need for its removal [32, 33].    
 
One of the advantages of using silk is that it is readily available and easy to 
process. The sericulture process is well-established and 400,000 tons of dry silkworm 
cocoons are available worldwide per annum for the textile industry and also for 
biomaterial applications. Silk can be easily fabricated into various forms for different 
kinds of purpose. Silk fibers can be reeled from cocoons and knitted together to form 
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structures with high tensile strength for use in ligament/tendon tissue engineering [34, 
35]. Non-woven silk fibroin mats with high surface area and rough topology could be 
created by electrospinning and culture with a variety of cells like keratinocytes, 
fibroblasts, osteoblasts [36]. Silk can also be used alone or blended with other 
polymers in aqueous or organic solvent systems to be cast into films. These films can 
have customizable properties in terms of oxygen permeability, degradability and 
surface roughness. There have been studies of the application of silk films in skin 
wound healing and bone formation. Hydrogels can also be formed from silk fibroin 
solution and be used in cell culture and drug delivery applications. Last but not least, 
silk can be used to fabricate porous sponge scaffolds. Sponges can be formed using 
porogens, gas foaming or lyophilization. These sponges are important in tissue 
engineering applications to regenerate various connective tissues like bone, cartilage 
and skin.  
 
Silk biomaterial is also able to undergo surface modifications using different 
methods. Proteins and ligands could be attached onto the silk fibroin surface via 
physical adsorption or chemical immobilization. Studies have demonstrated the use of 
integrin recognition sequence RGDS on silk fibroin to promote cell attachment and 
proliferation [37]. Silk fibroin can also be functionalized using the amino acid side 
chain chemistry. BMP-2 protein, which were immobilized instead of simply adsorbed 
on silk fibroin film led to increased bone marker expression from hMSCs [38]. Silk 
fibroin can also be modified to introduce a concentration gradient of signaling cues 
within the scaffold. These immobilized gradients within the scaffold have the potential 
to develop tissue constructs with more complex structural hierarchy. Silk can also be 
modified to create organic-inorganic composites through covalent linkage. 
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Hydroxyapatite crystals could be deposited onto silk scaffolds to form a composite 
scaffold for bone tissue engineering scaffolds.  
 
The degradation property of silk also makes it attractive as a biomaterial. 
Degradation of biomaterials is important because by matching the rate of scaffold 
degradation to the rate of tissue growth, it facilitates the restoration of tissue structure 
and function. Silk fibroin fibers have been shown to retain more than 50% of its 
mechanical properties after two months of implantation in vivo [39]. As a natural 
polymer, degradation of silk occurs via the action of proteases. This is unlike synthetic 
polymers where the degradation products could decrease local pH and lead to 
inflammation. The degradation rate of silk fibroin could be controlled by varying its 
crystallinity, pore size, porosity and molecular weight distribution [40].   
 
Silk biomaterial can be sterilized using different methods. Autoclaving of silk 
at 1200C does not change its morphology or β-sheet structure [41, 42]. Silk fibroin 
scaffold can also be sterilized using ethylene oxide, γ-radiation or 70% ethanol [43-45]. 
This makes it particularly attractive over some materials which can only be sterilized 
using specific means. For example, collagen-based scaffolds will denature when 
subjected to high temperatures [46]. 
 
2.3.4 Fabrication Methods 
Fabrication techniques play an important role in determining the final 
characteristics of the scaffold. These characteristics include mechanical strength, 
porosity, degradation rates, surface chemistry and the ability to incorporate 
biologically active molecules. There are many established processing and fabrication 
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methods which can be used to create scaffolds from polymers, proteins, peptides and 
inorganic materials. These include fibre bonding, electro-spinning, solvent casting and 
particulate leaching, melt molding, membrane lamination, extrusion, freeze drying, 
phase separation, high internal-phase emulsion, gas foaming polymer/ceramic 
composite fabrication, rapid prototyping, peptide self assembly, and in situ 
polymerization [13]. 
 
To identify a suitable fabrication method for the scaffold, there is a need for a 
set of selection criteria and a comparison of the various fabrication techniques. A 
suitable fabrication technique should fulfil the following criteria [47]. 
Processing conditions – The processing and fabrication conditions should not 
adversely change the biocompatibility, mechanical and chemical properties of the 
material. 
Process accuracy – The technique should be able to produce spatially and anatomically 
correct scaffolds.  
Consistency – The scaffolds should have highly consistent pore sizes with a narrow 
size distribution throughout the entire volume. There should also be consistency in 
pore characteristics, morphologies, pore distribution, pore density, and 
interconnectivity, so as to produce 3D scaffolds of high regularity.  
Repeatability – Under the same set of processing parameters and conditions, there 
should be minimal variations across scaffold batches in terms of physical forms and 
properties. It should be easy to achieve highly consistent and reproducible scaffolds. 
 
The table below summarizes the advantages and limitations of the conventional 
scaffold fabrication technologies that are available. 
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Table 2.1: Summary of the advantages and limitations of conventional fabrication 
techniques [47] 
Process Advantages Disadvantages 




High surface area to volume 
ratio 
High processing temperature for 
non amorphous polymer 
 
Limited range of polymers 
 
Lack of mechanical strength 
 
Problems with residual solvent 
 
Lack of control over micro 
architecture 
Phase separation Allows incorporation of 
bioactive agents 
 
Highly porous structures 
Lack of control over micro 
architecture 
 
Problems with residual solvent 
 
Limited range of pore sizes 
Solvent casting & 
particulate leaching 
Highly porous structures 
 
Large range of pore sizes 
 
Independent control of 
porosity and pore size 
 
Crystallinity can be tailored 
Limited membrane thickness 
 
Lack of mechanical strength 
 
Problems with residual solvent 
Residual porogens 
Membrane lamination Macro shape control 
 
Independent control of 
porosity and pore size 
Lack of mechanical strength 
 
Problems with residual solvent 
 
Tedious and time consuming 
 
Limited interconnected pores 
Melt molding Independent control of 
porosity and pore size 
 
Macro shape control 






Good compressive strength 
 
Independent control of 
porosity and pore size 





Organic solvent free 
 
Allows incorporation of 
bioactive agents 
Nonporous external surface 
 
Closed pore structure 
High pressure 
processing & particulate 
leaching 
Organic solvent free 
 
Allows incorporation of 
bioactive agents 
 
Highly porous structures 
Limited interconnected pores 
 






Large range of pore sizes 
 
Independent control of 
porosity and pore sizes 
Freeze drying High porous structures  
 
High pore interconnectivity 
Limited to small pore sizes 
Hydrocarbon templating No thickness limitation 
 
Independent control of 
porosity and pore sizes 




2.3.5 Freeze drying technique 
Freeze-drying / lyophilization is a dehydration process which works by 
freezing the material and then reducing the surrounding pressure to allow the frozen 
water to sublimate directly from the solid phase to the gas phase. The food industry 
uses freeze-drying to preserve food while the pharmaceutical industry uses it to 
increase the shelf life of vaccines and other injectables. Freeze-drying can also be used 
in tissue engineering applications to fabricate porous scaffolds with high 
interconnectivity.  
 
2.3.5.1 Process  
For tissue engineering purposes, the freeze-drying consists of three stages:  
Freezing – The material is first dissolved in solution and poured into a mold of 
specified dimensions. The material is then cooled using a freezer or the freeze-drying 
machine. It is important to cool the material below its triple point, the lowest 
temperature at which the solid and liquid phases of the material can coexist. Upon 
freezing, the material is frozen and localized between the ice crystals, forming a 
continuous, interpenetrating network of ice and material. The freezing is the most 
important process in the freeze drying process because the resultant scaffold can be 
spoilt if the freezing is done poorly. 
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Primary drying – In this phase, the pressure is lowered to the range of a few millibars 
and enough heat is supplied to the material for the water to sublime. Sublimation of the 
ice crystals results in the formation of a highly porous sponge. The resultant pore 
structure depends on the underlying freezing processes in the previous stage. In this 
initial drying phase, about 95% of the water in the material is sublimated. In this phase, 
pressure is controlled via the application of partial vacuum. The vacuum hastens the 
sublimation, making it useful as a deliberate drying process. 
 
Secondary drying – This phase aims to remove unfrozen water molecules, since the ice 
was removed in the primary drying phase. In this phase, the temperature is raised 
higher than in the primary phase and can be above 0oC in order to break any physic-
chemical interactions that have formed between the water molecules and the frozen 
material. 
 
 Freeze-drying is performed using the freeze-drying machine, typically made up 
of a vacuum pump to reduce the ambient gas pressure in a vessel containing the 
substance to be dried, and a condenser to remove the moisture by condensation on a 
surface cooled to -40 to -80oC. There are three categories of freeze dryers – the 
manifold freeze-dryer, the rotary freeze-dryer and the tray style freeze dryer. The tray 
style freeze dryer (Martin Christ, Epsilon 1-4 LSC, Denmark) is available for use in 
the author’s laboratory. 
 
2.3.5.2 Rationale for using freeze-drying 
The freeze-drying method of scaffold fabrications offers several advantages 
over other techniques. It offers ease of operation and highly customized scaffolds. The 
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user has control over the average pore size, scaffold shape and thickness by varying 
the concentration of solution and using customized molds to hold the solution. 
Through the process of freezing and drying, the empty space left behind by the 
network of ice crystals creates a highly porous and interconnected pore structure. 
Freeze-drying is an entirely physical process which does not require the use of 
porogens or any solvents. Hence, there is no risk of undesirable residual substances left 
in the scaffold. The physical nature of the process also does not change the properties 
of the material drastically. On the flip side, it is easy to incorporate bioactive agents to 
the scaffold and improve its properties. 
 
The drawbacks of using freeze-drying for scaffold fabrication would be the 
cost of the equipment and the lack of control over the micro-architecture. Freeze dryers, 
especially the higher end models with programmable controls, are quite costly for a lab 
to procure. In addition, unlike the FDM method of scaffold fabrication, the final pore 
structure created by freeze-drying is irregular and random. However, one could argue 
that an irregular and interconnecting architecture mimics the native architecture of 
ECM more closely than one with highly regular architecture.   
 
2.4 Bioreactors for Bone Tissue Engineering 
Bioreactors are devices or systems that create a closed culture environment 
which enables control of one or more environmental or operating variables that affect 
biological processes. In tissue engineering, bioreactors are used to provide controlled 
and reproducible environment for cell and tissue proliferation. Variables such as 
temperature, pH, gas concentration, medium flow rate, shear stress, hydrodynamics 
and mechanical forces could be controlled to closely mimic the in-vivo conditions [48]. 
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Applications of bioreactors in tissue engineering could be for growing 3D tissue 
constructs before implantation, expansion of cells for transplantation, and as organ 
support systems.  
 
2.4.1 Functions of bioreactors 
Bioreactors fulfill three main functions in tissue engineering applications, 
which are to provide a means for cell seeding, for transport of nutrients and waste, and 
to provide some form of mechanical stimuli to the cell-scaffold construct. 
 
2.4.1.1 Cell Seeding   
Seeding of cells into a scaffold is an important procedure as it could potentially 
affect the outcome of the tissue engineered construct. Seeded scaffold constructs 
should ideally have a high cell density and uniform spatial distribution of attached 
cells [49]. This will, in turn, lead to uniform tissue regeneration and effectiveness of 
the tissue engineered construct. The most common method of seeding cells is by static 
seeding, which involves pipetting a suspension of known cell density onto the surface 
of the scaffold. Cells are usually not able to penetrate into the central portions of the 
scaffold and would mostly reside at its periphery. Dynamic seeding using bioreactors 
are able to overcome this issue and produce cell seeded constructs that are uniformly 
distributed with high initial cell numbers.  This would eventually produce tissue 
constructs with better structure and composition. Examples of dynamic seeding 






2.4.1.2 Mass transport of nutrients and waste 
In tissue engineering, mass transfer involves the movement of nutrients and 
gases from the source of supply to the location of the cells. Mass transfer is governed 
by two processes – convective mass transfer and diffusion. Convective mass transfer, 
or simply the transport of molecules in the bulk motion of the media flow, is 
responsible for getting the nutrients to the vicinity of the scaffold and cells. Molecular 
diffusion then allows transfer of nutrients and wastes down a concentration gradient, 
through the scaffold structure and cell layers.  
 
For in-vitro culture of 3D tissues, the supply of oxygen and soluble nutrients 
becomes an important limiting factor as the size of scaffolds increases. In vivo, most 
tissues are on average 100 µm away from the nearest capillary which provides the 
required nutrients [50]. Studies with different types of cells cultured on 3D scaffolds 
have shown that under static conditions, a hypoxic and necrotic centre develops in the 
central region [51]. These observations meant that the tissue engineered construct 
would have poor outcomes whereby only the peripheral regions are well developed 
and the core of the construct is poorly formed. For engineered constructs to be 
meaningful as grafts for tissue replacement, it has to be at least a few millimeters in 
size. Hence, the limitation of mass transfer has to be adequately addressed. Bioreactor 
systems can overcome this problem as they are able to create a dynamic in vitro 
environment and create flow of medium into scaffold pores, supporting effective 






2.4.1.3 Mechanical stimulation 
Tissues in the body such as bone, cartilage, ligament and blood vessel are 
subjected to some form of mechanical forces in vivo. An increasing number of studies 
have shown that the use of mechanical forces in vitro could have a modulating effect 
on the bioactivity of the cells cultured on various culture models. Smooth muscle cells 
seeded on tubular scaffolds for blood vessel engineering showed improved structural 
organization and suture retention after being stimulated by pulsatile radial stress [52]. 
For chondrocytes seeded in 3D environments, the use of dynamic deformational 
loading stimulated GAG synthesis and increased the mechanical properties of the 
construct [53, 54]. Osteoblasts seeded on 3D scaffolds also showed increased 
mineralized matrix deposition after being subjected to fluid shear forces [55, 56].  
 
With regards to the above studies, bioreactor systems are fully capable of 
providing these mechanical stimulations to the tissue engineered constructs in a 
controlled and reproducible manner. Besides providing stimulation to enhance cell 
differentiation or ECM deposition in vitro, bioreactor systems are also useful as an in 
vitro model to examine the pathophysiological effects of physical forces on developing 
tissues, and to predict the responses of an engineered tissue to physiological forces on 
surgical implantation.  
 
2.4.2 Types of bioreactors 
The common types of bioreactors are spinner flask, rotating wall vessel (RWV) 





2.4.2.1 Spinner flask  
 
Figure 2.1: Schematic representation of a spinner flask bioreactor. This can be used for 
seeding of cells into 3D scaffolds and subsequent culture of the constructs [57]. 
  
A typical spinner flask setup is made up of cell-seeded scaffolds attached to 
needles and suspended from the cover of the flask. Sufficient medium is added to 
cover the scaffolds. Movement of the medium is created by the magnetic stirrer at the 
bottom when the flask is placed on a magnetic stirrer plate. Consequently, the 
convective forces produced by the magnetic stirrer helps to alleviate the nutrient 
concentration gradients at the surface of the scaffolds [58]. Applications of spinner 
flask in bone tissue engineering have been done in several studies and the results 
demonstrated that the convective medium flow improves cell proliferation and 
osteogenic differentiation as compared to the controls [59-61]. Disadvantages faced 
when using spinner flasks are the amount of time needed for seeding (typically 24 h), 
low efficiency at low cell concentrations, and undesirable side effects associated with 









2.4.2.2 Rotating Wall Vessel (RWV) 
 
Figure 2.2: Schematic representation of a RWV.  Constructs are placed in a dynamic 
culture environment with low shear stresses and high mass transfer rates. The vessel 
walls are rotated at a rate such that the drag force (Fd), centrifugal force (Fc) and net 
gravitational force (Fg) on the construct are balanced [57]. 
 
The RWV was first developed by NASA to simulate microgravity effects. A 
typical setup of the RWV is composed of two concentric cylinders and the micro-
carriers or scaffolds are positioned in the annular space between the two cylinders. Gas 
exchange occurs through the stationary inner cylinder while the outer cylinder is 
impermeable and rotates in a controlled fashion. Under carefully selected rotational 
rates, the free falling of the scaffolds inside the bioreactor due to gravity can be 
balanced by the centrifugal forces due to the rotation of the outer cylinder, thus 
establishing microgravity-like environment. A microgravity environment creates low 
shear stress conditions and promotes cell-cell association, which was conducive for 
tissue reconstruction applications. Osteoblast-like cells seeded on lighter-than-water 
polymer scaffolds and cultured in a rotating bioreactor showed increasing ALP activity 
and mineralization [62]. Although the RWV bioreactor has been efficient in reducing 
the boundary layer surrounding the construct surface, it did not solve the problem of 





2.4.2.3 Perfusion bioreactors 
 
Figure 2.3: Schematic representation of a direct perfusion bioreactor. Medium flows 
directly through the pores of the scaffold. The system can be used for seeding and/or 
culturing of constructs [57]. 
 
Perfusion bioreactor is a type of bioreactor that is designed to continuously 
flow media either around or through a porous scaffold seeded with cells. Perfusion 
systems typically consist of the bioreactor body to house the scaffolds, a reservoir to 
store the medium, and a peristaltic pump to circulate the medium. The pump is used to 
perfuse medium through the interconnected pores of the scaffolds and ensure the 
continuous availability of nutrients during culture.  In order to guarantee that the 
exchange of medium occurs within the pores of the scaffolds, the fluid path must be 
confined such that the flow path is through the seeded scaffold and not around it. The 
entire perfusion system may be designed as a stand-alone setup or be placed inside an 
incubator. In both kinds of setups, the important parameters like flow rate, humidity, 
pH, pO2, pCO2, and temperature need to be controlled and monitored. Through 
meticulous control of these settings, perfusion bioreactors are able to achieve better 
outcomes in the cultivation of tissue engineered construct. 
 
Several groups have had success with using perfusion bioreactor systems in 
bone tissue engineering. Mueller et al reported enhanced viability, ALP activity and 
mineralization when murine K8 osteosarcoma cells seeded on 3D collagen sponges 
was cultured in a flow perfusion bioreactor [64]. Similarly, Goldstein et al 
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demonstrated better outcomes in terms of cell uniformity and ALP activity when rat 
MSCs were seeded on 3D porous biodegradable polymer foams and cultured in a 
perfusion bioreactor, as compared to a spinner flask and a rotating wall vessel [65]. A 
significant amount of work on perfusion bioreactors has also been done by Mikos 
AG’s group [55, 56, 65-67]. In particular, they have shown that mechanical shear 
stress in perfusion systems is able to stimulate osteogenic differentiation. Mineralized 
matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases 
with increasing fluid shear forces [55]. 
 
High flow versus low flow (pros and cons): High flow rate allows for high 
nutrient concentration but the increased shear forces might produce a negative cell 
response. Hence, it might be better to have a low flow system designed to enhance 
nutrient transfer without any mechanical stimulation [68]. One of the problems 
associated with direct perfusion bioreactors is the non-uniform cellular secretions 
through the thickness of the construct as well as damage to some of the cells. If fluid is 
flowing from one side of a scaffold to the other, then the front surface will have a 
greater mechanical stress exerted on it because of the oncoming flow. Conversely, the 
back surface does not feel the force except for the insides of the pores. This will cause 
a thicker matrix to form on the front side of the scaffold as compared with the rest of 
the construct [58]. 
 
2.5 Biophysical Stimulations for Bone Tissue Engineering 
2.5.1 Ultrasound 
Low intensity pulsed ultrasound (LIPUS) is a widely used, clinically 
established and FDA approved intervention for accelerating bone growth during 
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healing of fractures, non-union and other osseous defects [69]. Ultrasounds like LIPUS 
are longitudinal waves of alternating pressure deviations from the equilibrium pressure, 
causing regions of compressions and rarefactions. As ultrasound passes through a 
medium, it is exponentially attenuated and can be described by the following equation:  
 
I = I0 e-µX,  where  I: Target intensity of the sound wave; 
I0: Initial intensity 
µ: Intensity attenuation coefficient 
X: Distance travelled by the sound wave  
 
These mechanical perturbations act on the ECM of the target cells, providing 
stimulation. The amount of energy delivered is dependent on the matrix composition 
of the overlying tissue through which the waves traverse. It also depends on the 
coupling between the transducer and the sample [70, 71]. Therapeutic ranges of 
ultrasound which are known to promote healing, bone deposition and growth vary 
between frequencies 0.5 to 1.5 MHz and intensities 30 to 200 mW/cm2 [69]. In 
practice, LIPUS is mainly used at 30 mW/cm2 intensity for augmentation of bone 
fracture repair [72, 73] fixation of orthopaedic implant [74], non-union healing [75, 76] 
and distraction osteogenesis [77-79]. The mechanism by which LIPUS induces the 
healing responses is still unclear, but it is known that the rate of fracture healing is 
induced when the cells that receive the mechanical strains translate it into biochemical 
events [69]. 
 
In vitro studies have been done to investigate the direct effects of LIPUS on 
bone formation. Warden et al showed in vitro that LIPUS stimulated the expression of 
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c-fos and cyclooxygenase-2 genes and elevated mRNA levels for the bone matrix 
proteins ALP and osteocalcin [80]. Ultrasound also stimulated osteoblast 
differentiation by increasing ALP, osteocalcin and VEGF expression and 
mineralization, with the effects more pronounced using higher ultrasound intensities 
[81, 82]. Chen et al found an increased cbfa-1 and osteocalcin expression in human 
osteoblast after LIPUS treatment [83].  
 
In vivo studies have been done on intact bone and have been demonstrated that 
LIPUS does not stimulate osteogenesis in intact bone. LIPUS applied on the femur of 
4-week old growing male rats had no effect on its longitudinal growth or bone mineral 
density [84]. Warden et al similarly reported that the administration of LIPUS 
treatment had no effect on bone mineral content or bone mineral density within the 
distal femur or proximal tibia of ovariectomy rats or normal rats following sham 
ovariectomy [80]. Therefore, the results of in vivo studies on intact bone model 
seemed to suggest that LIPUS treatment does not affect bone remodelling.  
 
On the other hand, the application of ultrasound on bone fractures has seen 
positive outcomes in many studies. LIPUS seemed to play a greater role during the 
early inflammatory or callus formation phase of healing. LIPUS treatment during 
fracture healing was able to speed up the restoration of mechanical properties of bone, 
such as maximum torque and torsional stiffness. When ultrasound was applied during 
the inflammatory and early proliferative phase of bone regeneration, there was 
accelerated fracture healing. But when applied in the late proliferative phase, it 




One of the challenges in studying the biological effects of LIPUS in a clinical 
setting is how to determine the precise energy delivered to the target cells in order to 
achieve therapeutic effects. For example, when LIPUS is used for bone fracture 
applications, the soft tissues around the fracture will attenuate the ultrasound intensity, 
resulting in the periosteal surface receiving a much lower intensity than applied.  
 
2.5.2 Electromagnetic Field 
2.5.2.1 Electromagnetic Stimulation in Clinical Applications 
Electromagnetic field stimulation has been applied clinically to promote bone 
healing for the past three decades. Bone stimulation is usually used in orthopaedics for 
treating delayed unions and non-unions of tibial fractures, base of fifth metatarsal 
fractures, ankle fractures and as an adjunctive treatment in forefoot and hindfoot 
arthrodesis [85]. In fact FDA approved the following three technologies: Pulsed 
electromagnetic field (PEMF) technology using noncontact coils, sinusoidal electric 
field (SEF) technology using skin contact electrodes and direct current technology 
using surgically implanted electrodes [86]. More than 250,000 patients have been 
treated with the three above-mentioned technologies, with the majority of them 
receiving the PEMF option [87, 88]. The success rates of these treatment range from 
65 to 90%, dependent upon other factors like infection, prior operation and patient 
compliance. A shorter elapsed time since initial trauma will also ensure higher success 
rate. Many in vivo and clinical studies involving tibial, scaphoid and other fractures 
have proven that pulsed electromagnetic field is a safe and effective treatment for non-





2.5.2.2 Electromagnetic stimulation on osteoblasts in vitro 
It has been reported that low frequency PEMF stimulation of osteoblasts can 
increase their proliferation and differentiation [97-106]. PEMF effects are dependent 
on the maturation stage of the osteoblasts [99], the percentage of fetal calf serum in the 
culture medium [105], as well as intensity, frequency and exposure time of PEMF. 
These findings suggested that PEMF stimulation with specific parameters had an effect 
on regulating the osteoblasts’ proliferation and differentiation. A summary of PEMF 
stimulatory effects is shown in Table 2.2. In addition, PEMF has been shown to up-
regulate the production of ECM, growth and differentiation factors including TGF-β1, 
BMP-2 and BMP-4 in many experimental models (Table 2.3). However, PEMF 
dependent changes in mRNA levels of TGF-β1, BMP-2, -4 and -7 and their receptors, 
had considerable variability in responses, perhaps explaining in part the variance in 















Table 2.2: Summary of PEMF studies done on bone cells in vitro. (P = proliferation; D 
= differentiation; M = mineralization) 







0.13, 0.24, 0.32 mT 




2h, 8h per day, 





 PLGA scaffold of  
85% porosity 
0.13mT enhanced P and D 
0.24mT inhibited P and 
enhanced D 






15 Hz,  
5ms burst of 20 
square waves, 
24 hr per day, 
28 day culture 
MC3T3-E1 
 
Cells exposed at 
specific stages of 
osteogenesis 
Exposure to PEMF at P 
stage enhanced P, D and M 
Exposure at D stage 
enhanced D and M 










Rat calvaria primary 
osteoblast 
No effect on MC3T3-E1 
Exposure at P stage 
enhanced P and inhibited D 







5 ms burst of 20 
pulses, 
8hr per day, 




Cell number ↓ 










5 ms burst of 22 
pulses, 




10%FBS  1% FBS 
under stimulation 
Cell number ↑ 
ALP ↓ 
Mineralized nodule 
formation no change 
OPG mRNA ↑ 
NF-kB ligand mRNA ↓ 
Collagen I, osteocalcin and 






75 Hz,  
1.3ms, 
6-9 hr, 24hr 
Human osteoblast  
10% FBS 
Cell proliferation increased 










like cells  






Human osteoblast like cells: 
10% FCS led to increase in 
proliferation 
0.5% FCS led to decrease in 
proliferation 
MG63 cells: Both 10% and 





Table 2.3: Summary of studies investigating PEMF regulation of TGF-β / BMP 
 
2.5.2.3 Electromagnetic stimulation on mesenchymal stem cells in vitro 
Mesenchymal stem cells are found in different tissues such as the bone marrow, 
adipose tissue and umbilical cord blood [111]. However, the bone marrow is 
considered as the original and most significant source of MSCs. MSCs have the 
capacity to differentiate into many cells types which primarily include osteoblasts, 
chondrocytes and adipocytes [111]. In the bone marrow tissue, a significant fraction of 
MSCs is differentiated into osteoblasts, especially when the organism is undergoing 






15min, 30min and 
60min 
21 day culture 
 
Osteoblasts Proliferation ↑ 






24h per day 
19 day culture 




0.002 - 0.1mT (peak) 
60Hz 
6-7h per day 
20 day culture 
Endochondral 
ossification in vivo 
Differentiation ↑ 







8h per day 
4 day culture 
MG63 osteoblasts Differentiation ↑ 






8h per day 
4 day culture 
Human non union 
cells 






8h per day 
10 day culture 
Endochondral 
ossification in vivo 
Differentiation ↑ 






8h per day 
4 day culture 
MLO-Y4 TGF β1 ↑, PGE2 ↑ 
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fracture healing [112]. As we have seen in the previous section that extensive studies 
have been carried to assess the effects of PEMF stimulation on osteoblasts and 
regenerative effects of PEMF have been widely observed, it is quite necessary to also 
evaluate the effects of PEMF stimulation of the differentiation of MSCs to an 
osteoblastic lineage (osteogenesis). 
 
Even though PEMF has shown to have direct effects on the proliferation and 
differentiation of osteoblasts, it has not exhibited any direct osteogenic inductive effect 
on MSCs [113]. Schwartz showed that while PEMF regulates osteogenesis of MSCs, 
an osteoblast-inductive stimulus such as osteogenic medium or BMP-2 is still required 
to induce differentiation in MSCs. In other words, MSCs are sensitive to PEMF only 
when they are committed to an osteoblast lineage.  
 
As mentioned earlier, PEMF effects on osteoblasts are dependent on a few 
parameters like the intensity, frequency and exposure time of the magnetic field [114, 
115]. However, extending the same conclusions is to MSCs is not possible without 
detailed studies. The exact mechanism how PEMF exposure alters the differentiation 
and proliferation of mesenchymal stem cells is still not understood. It has been 
hypothesised that PEMF stimulation might affect the function of membrane integral 
proteins that would in turn alter membrane potentials. This would therefore result in 
the alteration of the cell cycle progression and affect proliferation [116]. The study of 
PEMF on MSCs is relatively new and related publications are recent and few. A 
summary of recent PEMF stimulation studies on mesenchymal stem cells is provided 
in Table 2.4. Therefore, there is a need to study the effects of PEMF on the 
osteogenesis of MSCs.  
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Table 2.4: Summary of findings from studies of PEMF on MSCs 
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2.5.2.4 Mechanisms of electromagnetic field stimulation on cells 
PEMF therapy has been used successfully to treat a wide spectrum of bone 
related problem for many years, including non-union fractures and osteoporosis. 
Despite its clinical efficacy, the mechanism by which PEMF stimulation induces 
cellular proliferation and bone regeneration remains unclear. However, it has been 
suggested that the calcium/calmodulin pathway is involved. Unlike electric fields, 
where signal transduction occurs by means of calcium ion translocation through 
voltage-gated calcium channels, PEMF signal transduction seems to be mediated by 
the release of intracellular calcium leading to increases in cytosolic calcium and 
activated calmodulin [119]. Zhang et al showed that the effects of PEMF on osteoblast 
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were also dependent on the ECM, P2 receptor on the cell membrane and PLC pathway 
[120]. Bone healing, when seen from a cellular perspective, involves a complex 
interaction of growth factors, signal transduction and the physical environment. 
Electrical potentials have been shown to upregulate the local growth factors 
[transforming growth factor-β (TGF- β)], thereby affecting the proliferation of 
osteoprogenitor cells from the periosteum, the conversion of cells to osteoblasts and 
osteocytes [108].   
  
2.6 Hypothesis, Objectives and Scope 
2.6.1 Summary of literature review 
Based on the literature review, it was established that with a rapidly aging 
population, there is an increasing demand for bone grafts which cannot be satisfied by 
currently available bone grafts (autografts, allografts and synthetic grafts). To cope 
with this shortage, tissue engineered bone grafts present itself as a potential solution. A 
successful bone tissue engineering strategy hinges on the choice of three important 
components: a suitable scaffold to support bone growth, a suitable cellular source 
which can be easily isolated and expanded, and an appropriate in vitro culture system 
to culture the cell-seeded construct over prolonged periods. This also makes bone 
tissue engineering highly dynamic as there is a considerable range of materials, cells 
and systems to choose from, and they can be used in a variety of combinations.  
 
Also, in this project, PEMF stimulation will be applied to study its effects on 
the osteogenesis development of BMSCs cultured in OS medium. PEMF is a FDA-
approved technology used for treating delayed unions and non-unions of fractures. It 
has seen clinical success with patients and has been proven to be a safe and effective 
46 
 
treatment. Studies have been done in vitro by applying PEMF stimulation to bone cell 
cultures and have shown beneficial effects in terms of proliferation, differentiation 
and/or mineralization.  
 
BMSCs have been shown to be a promising cell source for bone tissue 
engineering. BMSCs are easy to isolate due to their adherence to plastic and can be 
easily expanded in vitro. Induction of BMSCs down the osteogenic lineage is also well 
established. Among the mesenchymal cell sources, BMSCs are the most well-studied 
and characterized. This makes it particularly attractive for this project where there are 
few or no prior studies of PEMF stimulation on MSCs before. Being well 
characterized means having a wealth of resources for reference in the event of doubts 
occurring. 
 
Silk has been demonstrated to be a suitable material for tissue engineering. It is 
readily available and easy to process into various shapes, size and architecture. It can 
also be combined with other materials and undergo surface modifications. The slow 
degradation rate of silk also makes it attractive for bone tissue engineering. Many 
studies have demonstrated the efficacy of using silk in bone tissue engineering 
applications. The freeze drying technique would be used to create porous scaffolds 
from the silk material.  
 
Bioreactors have demonstrated their effectiveness for cultivation and 
development of tissue engineered bone grafts. Constructs with larger dimensions can 
be cultured in bioreactors, thus making it more relevant for treating critical size defects. 
A perfusion bioreactor system was chosen in this project because the design of the 
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perfusion chamber ensures that medium is perfused directly throughout the entire 
scaffold, thus ensuring a continuous supply of nutrients and preventing accumulation 
of wastes. Bioreactors are also capable of providing mechanical stimulation to the 
constructs. The flow of medium creates fluid shear force which was shown to increase 
the production of mineralized matrix. Therefore, mechanical stimulation in this study 
will be provided by the perfusion bioreactor system. 
 
2.6.2 Significance and Originality of Work 
After reviewing the current literature on in vitro PEMF studies, the investigator 
has identified three gaps. Firstly, most of the studies were done on bone cells like 
osteoblasts, osteoclasts and osteosarcoma cell lines. At the start of this project, there 
were no studies investigating PEMF effects on BMSCs. Given the important role of 
BMSCs in fracture healing and the known therapeutic effects of PEMF on fracture 
healing, it would be worthwhile to study PEMF effects on BMSCs. Secondly, most of 
these studies were performed in 2D culture systems. Bone cells live in a 3D 
environment within the body and the results from 2D culture models might not 
accurately portray the cellular responses to PEMF stimulation in a 3D setting. A 3D 
scaffold would be able to provide a more appropriate environment for this purpose. 
Thirdly, there is no reported study of BMSCs being exposed to both mechanical and 
PEMF stimulation in vitro. Hence, the effects are still unknown.  
 
This project will work on filling the gaps mentioned above by investigating the 
effects of BMSCs in various culture systems. The starting point would be PEMF 
stimulation on BMSCs in static 2D culture plates, subsequently moving on to static 3D 
constructs cultured in culture plates, and finally to 3D constructs cultured in dynamic 
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bioreactor systems. The investigator believes that PEMF technology has the potential 
to augment current bone tissue engineering techniques in producing better quality bone 
grafts and address its ever increasing demand.  
 
2.6.3 Research Objectives 
The research objective of the project is to study the effects of PEMF and 
mechanical stimulation on the process of osteogenesis in MSCs. This is done through 




The hypotheses of this project are: 
(1) BMSCs cultured in osteogenic supplemented (OS) medium and exposed to PEMF 
stimulation will result in improved ECM mineralization 
(2) The combined stimulation of fluid flow and PEMF stimulation on BMSCs seeded 
in silk scaffolds and cultured in OS medium will result in synergistic effects in 
production of mineralized ECM 
 
2.6.5 Specific Aims 
The specific aims of this project are as follows: 
(1) Demonstrate proof of concept that PEMF stimulation affects the osteogenic 
development of BMSCs. 




(3) Develop a perfusion bioreactor system and demonstrate its proof of efficacy in 
culturing tissue engineered bone constructs. 
(4) Investigate the effects of combining PEMF stimulation and mechanical stimulation 
via fluid flow on the production of mineralized ECM in BMSCs seeded on silk 
scaffolds. 
To achieve the objectives and specific aims, the project was planned to be 
conducted in four stages. In stage one, the BMSCs was isolated from the rabbits and 
characterized. A PEMF stimulation unit was designed and built. BMSCs was cultured 
in 2D culture plates and exposed to PEMF stimulation. A proof of concept was done to 
show that PEMF stimulation affected the osteogenic development of BMSCs and led 
to enhanced mineralized ECM formation.  
 
In stage two, a silk-based sponge scaffold was fabricated and characterized. 
BMSCs were seeded into the scaffold to demonstrate that the scaffold was suitable for 
bone tissue engineering. The cell-seeded construct was also exposed to PEMF 
stimulation to study its effects on cells in a 3D static culture model.  
 
In stage three, a perfusion bioreactor system was designed and fabricated. This 
system was used to provide cell-seeded constructs with a dynamic 3D environment. 
The bioreactor was characterized and in-vitro studies were done to demonstrate that 
the system supported bone tissue development.  
 
In the final stage, the PEMF stimulation and bioreactor system were integrated 
such that the constructs within the perfusion chambers would be subjected to PEMF 
stimulation. This setup was used to prove the hypothesis that combined mechanical 
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Stage I: Establish culture of BMSCs and Proof of concept of PEMF 
stimulation on BMSCs 
3.1 Experimental Setup – Materials and Methods 
3.1.1 Isolation and culture of BMSCs from rabbit model 
Rabbit MSCs were isolated from the bone marrow aspirates of New Zealand 
White rabbits (average weight 2.5kg) under the approval of the NUS Institutional 
Animal Care and Use Committee, National University of Singapore, according to 
protocols previously described. In brief, the rabbits were anaesthetized before bone 
marrow was aspirated from their iliac crest. Aspirated bone marrow was collected in a 
polypropylene tube containing preservative-free heparin (1000 units/ml). Every 5ml of 
bone marrow aspirate was subsequently diluted in 10ml of culture medium containing 
Dulbecco’s modified Eagle’s medium (DMEM) with low glucose, L-glutamine, 
110mg/L Na-Pyruvate, Pyridoxine HCl (GIBCO, Invitrogen Corporation, CA), fetal 
bovine serum (FBS) (15% w/v; GIBCO), and plated into culture flasks. BMSCs were 
incubated at 37oC, 5% humidified CO2 and selected based on their property of short-
term adherence to tissue culture polystyrene. Non-adherent cells were discarded after 
24 hours and adherent cells were cultured with medium changed every 3 to 4 days. 
Once reaching near confluence, the cells were detached via trypsinization and serially 
sub-cultured. Near confluent cells from passage one was frozen and stored in liquid 






3.1.2 Demonstration of BMSCs’ osteogenic potential 
The osteogenic potential of the BMSCs need to be proven before they could be 
used in subsequent experiments. Cells from the third passage were used in this 
experiment. The rationale for this is because a large number of cells would be needed 
in later stage experiments. Hence, it is needed to show here that the cells, after being 
passaged a few times, still retain their ability to differentiate into osteoblasts.   
 
Frozen vials containing BMSCs from passage one were thawed and plated in 
T175 culture flasks to be maintained in the incubator at 37oC and 5% humidified CO2. 
The cells were expanded once via sub-culturing and passage three BMSCs were used 
to demonstrate osteogenic ability. Once near 95% confluence, the cells were harvested 
using trypsin treatment. The cells were counted using a hemocytometer, after which 
they were seeded into 24-well plates at a seeding density of 3000 cells/cm2 (equivalent 
to 6000 cells per well). The study group was cultured under osteogenic condition with 
high glucose DMEM supplemented with 15% FBS (HyClone, Logan, UT) and 1% 
antibiotics (200 units/ml penicillin G and 200 units/ml streptomycin sulfate), 10 nM 
dexamethasone (Sigma), 50μg/ml L-ascorbic acid, and 10 mM β-glycerophosphate. 
The control group was cultured in DMEM with low glucose (Gibco, Invitrogen, CA) 
supplemented with 15% FBS and 1% antibiotics. The decision to use osteogenic 
chemicals to induce osteogenic differentiation in BMSCs is because it is a well 
established method. The alternative method would be to use bone morphogenetic 
protein 2 (BMP-2). However, BMP-2 is very expensive and would incur high 
consumables cost for this project. Both groups were maintained in the incubator at 
37oC and 5% humidified CO2 over a period of 21 days. Media change was done every 
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3 days. Samples were harvested on day 2 and subsequently on days 7, 14 and 21 for 
assays and histology. 
 
3.1.3 Pico green assay 
Samples (n = 4) from each group were collected to assess cell proliferation. 
The measurement of the cell number in each well was assessed using the Quant-iT 
PicoGreen dsDNA reagent kit (Invitrogen, CA), which is an ultrasensitive fluorescent 
nucleic acid stain for quantitating double-stranded DNA in solution. Samples were 
washed with PBS and treated with Buffer RLT Qiagen) cell lysis buffer. The cell 
lysate was transferred into a centrifuge tube, where the contents were homogenized via 
repeated pipetting. A fresh tip was used for each sample and care was taken to try and 
minimize the loss of homogenate. The tubes were vortexed for 5 minutes and then 
centrifuged at 16,000 rpm for 5 minutes. 20 µL of cell lysate was mixed with 80 µL of 
PicoGreen dye, prepared based on the manufacturer’s protocol, in 96-well black plates. 
Fluorescence intensity was measured using a FLUOstar Optima fluorescent plate 
reader (BMG Labtech, Offenburg, Germany) at 520 nm wavelength after excitation at 
485 nm, using a gain of 1000, 10 flashes per well and a position delay time of 0.2 to 
0.5s. The relative fluorescence unit value read using the machine was compared 
against a DNA standard curve to obtain the DNA content in each sample. 
     
3.1.4 ALP assay 
To assess the osteogenic differentiation of the cells, ALP activity of the 
samples (n = 4) were measured using the Phosphatase Substrate Kit (PIERCE). 
Samples were first washed with PBS, and then incubated with 500 µL solution of para-
nitrophenyl phosphate (pnPP) disodium salt in Diethanolamine Substrate Buffer 
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(1mg/ml) for 1 hour in a humidified atmosphere of 5% CO2 at 370C. After 1 hour, 250 
µL of 2N sodium hydroxide was added to stop the reaction. The absorbance values 
were measured at 405 nm immediately using a microplate reader. The ALP activity 
was calculated using the formula given by the manufacturer.  
  
3.1.5 Calcium content assay 
To measure the amount of calcium deposited during osteogenesis, a 
colorimetric assay based on the calcium O-cresolphthalein complexone methodology 
was carried out using the Calcium (CPC) LiquiColor test (Stanbio Laboratory, TX). 
Samples (n = 4 per group) were first washed with PBS and then incubated with 500 µL 
of 5% trichloroacetic acid (TCA) at room temperature for 30 minutes. The samples 
were transferred to a micro-centrifuge tube and centrifuged at 16,000 rpm for 5 
minutes to sediment the cell debris. 30 µL of each sample was added to 300 µL of the 
working reagent. Aliquots of 100 µL were pipetted in triplicates into 96-well plates. 
Absorbance values were measured at 575nm using a microplate reader. A standard 
curve was done using the calcium standards provided by the manufacturer and the 
absorbance readings of the samples were read off the standard cure to obtain the 
concentration of calcium in each sample.     
 
3.1.6 RT-PCR 
To examine the expression of osteogenic-related genes at different time points, 
mRNA expressions levels of Runx2/Cbfa-1, collagen type I, osteonectin and 
osteopontin were determined using real time quantitative polymerase chain reaction 
(RT-PCR). Samples (n = 3) were washed with PBS and harvested via trypsin treatment. 
The cell suspensions were centrifuged at 16,000 rpm for 5 minutes to obtain the cell 
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pellets. A commercial RNeasy Mini Kit (Qiagen, Hilden, Germany) was used to 
extract, wash and elute the RNA from the samples following the manufacturer’s 
protocol. RNA was reverse-transcribed in cDNA according to the manufacturer’s 
protocol (iScript cDNA synthesis kit, BioRad Laboratories, CA). RT-PCR was done 
using the iQ SYBR Green Supermix (Bio-Rad Laboratories, CA). The PCR system 
comprised of 12.5 µL SYBR Green dye, 4 µL of cDNA, 5 µL of primer with the 
optimal concentration and topped up to 25 µL with nuclease-free water. All reactions 
were performed on the MyiQ2 Real-Time PCR detection system. The level of 
expression of the target gene was normalized to GAPDH, the housekeeping gene, and 
calculated using the 2ΔCt formula. 
 
3.1.7 Alizarin Red Staining 
Presence of mineralization was also determined using Alizarin red staining. 
The culture medium was discarded and the samples were washed with PBS to remove 
residual medium. Next, the samples were fixed by soaking in 500 µL of 3.7% 
formaldehyde for 1 to 2 minutes. Each sample was subsequently immersed in 500 µL 
of 2% Alizarin red solution for 1 minute. The Alizarin red dye was removed and 
samples were rinsed with distilled water to remove any traces of excess dye. Samples 
were then viewed under the light microscope.  
 
3.1.8 PEMF Apparatus 
The PEMF stimulation setup was comprised of three components: 
Waveform generator – This component is responsible for producing controlled 
electrical signals. The frequency, intensity and shape of the output electrical signals 
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can be varied using this component. A commercially available product was used as the 
waveform generator (Instek SFG-2120 function generator) 
Amplifying circuit – Since the waveform generators that are commercially available 
have limited power output, it is not possible to have a very high output current from 
them which are necessary for stronger magnetic field strengths. Hence, an amplifying 
circuited was designed, tested and fabricated to take low current signals from the 
waveform generator and amplify them to the desired levels.  
Solenoid – These are basically large copper wire coils that house the cell cultures 
inside the incubator. When the current from the amplifying circuit runs through the 
solenoid, electromagnetic fields are produced and the cell culture positioned within 
will be exposed to this magnetic field. The characteristics of the magnetic fields 
(frequency, intensity, pulse shape) can be changed by changing the electrical signal 
parameters at the waveform generator and the amplifying circuit. 
 
3.1.9 Design and fabrication of solenoids 
 
Figure 3.1: Magnetic field lines created by the flowing current through the wire 
 
Equation (1) describes the magnetic field (B) along the internal axis of a solenoid 
having a finite length (2a). 
57 
 
        𝐵 = 𝜇0 �𝑁𝐿 𝑖� � (𝐿 + 2𝑎)2[𝐷2 + (𝐿 + 2𝑎)2]1 2⁄ + (𝐿 − 2𝑎)2[𝐷2 + (𝐿 − 2𝑎)2]1 2⁄ �                  (1) 
The cell cultures will be placed at the centre along the length of the solenoid. Hence 
the value of 𝑎 = 0 
                                    𝐵0 = 𝜇0 �𝑁𝐿 𝑖� � 𝐿(𝐷2 + 𝐿2)1 2⁄ �                                                   (2) 
For a long solenoid, 𝐿 >> 𝐷 and thus, (𝐷2 + 𝐿2)1 2⁄ ≈ 𝐿, then 
                                                        𝐵0 = 𝜇0 𝑁𝐿 𝑖 = 𝜇0𝑛𝑖                                                 (3) 
Since the maximum current outputs of the amplifier and waveform generator 
are known, the length of the solenoids could be determined using Equation (3). The 
limiting factor in the dimensions of the solenoid came from the capacity of the 
incubator, as up to six solenoids would be required to house in the incubator. Therefore, 
the length of the solenoid should allow it to fit into the incubator and have ample space 
for the user to handle cell culture samples into and out of the solenoid.  





𝑍 = 2𝜋𝑓𝐿 
 
𝐼0 = 𝑉𝑅 �1 − 𝑒−𝜏 𝑧⁄ � 
Where L = inductance of solenoid 
            μ0 = magnetic permeability of free space, 4π x 10-7 
            N = no of turns of copper wire 
            A = cross sectional area of solenoid 
             l = length of solenoid. 
Where Z = impedance of solenoid 
            f = frequency of field 
              
Where I0 = peak current 
            V = voltage supplied by waveform generator 
            R = resistance of solenoid 
            T = L/R 
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The final length of the solenoid was selected to be 32 cm and the internal 
diameter was 7 cm. To generate a high number of turns in the solenoid that were 
necessary to improve impedance and field generation potential, four concentric coils of 
copper wire need to be laid onto the core. Since the weight of copper wires alone 
would have caused such a structure to collapse, a hollow cylinder made from acrylic 
was used as the core of the solenoid to support the coils. An insulated copper wire of 
0.85 mm diameter was used. Since the assembly was quite bulky, the winding process 
was carried out on a lathe machine at the NUS Mechanical Engineering Department 
Fabrication Support Centre. Acrylic stoppers were placed at the ends of the assembly 
to prevent the copper wires from unwinding. To aid controlled delivery of wire during 
the winding process, a wire tension assembly was used. Figure 3.2 shows the setup that 
was in place at the Fabrication Support Centre and how a completed solenoid looks 
like. A total of six solenoids were fabricated to provide sufficient space for housing 
samples from the different experimental groups. 
 
 
Figure 3.2: (Left) Photograph showing an acrylic cylinder mounted on a lathe machine. 
Four layers of enameled copper wire were wound onto the cylinder. (Right) 






3.1.10 Magnetic field testing 
The calculations that were done prior to the fabrication of solenoids only 
provided a rough estimate of magnetic fields that were produced. This was because 
many parameters, such as the permeability of free space, exact number of turns and the 
exact amount of current flowing during testing conditions could not have been 
calculated or monitored reliably. Hence the strength of the magnetic field was 
measured using a magnetic field sensor (Vernier Magnetic Sensor with Go Link 
Interface device). The spatial distribution of the magnetic field was determined at the 
start of each study. Figure 3.3 below shows the distribution of magnetic field along the 
length of the solenoid. Magnetic field strength was subsequently monitored twice a 
week during medium change to ensure a consistent PEMF intensity throughout the 
course of each study. 
 
Figure 3.3: Chart showing how the PEMF field strength was distributed along the 






3.1.11 Design and fabrication of amplifying circuit 
As noted earlier, the waveform generator (Instek, SFG-2120) used for 
producing the input electrical signal had a limited power output. This particular device 
has to have a minimum load of 50 Ω attached to its output terminals. If the load 
impedance is below 50 Ω, signal distortion occurs firstly because a high output current 
requirement is not met by the device which ultimately results in a huge plummet in the 
output voltage. Secondly a very high current requirement compromises the 
waveform’s shape which would mean the magnetic field too will deviate from the 
required waveform. 
  
The solenoids that were fabricated only had a resistance of 15 Ω. Moreover, 
since the study worked with very low frequencies of not more than 35 Hz, the reactive 
component of the solenoid’s impedance was negligible. Such low impedance meant 
that a power gain circuit would be required. Hence it was decided that an amplifying 
circuit should be connected between the solenoids and the waveform generator. The 
circuit accepts a signal from the waveform generator and amplifies it before feeding it 
to the solenoid. It was understood that circuit should have the following properties: 
(1) High input impedance – This will be the impedance which the function generator 
will be facing (note that a higher impedance means a ‘lower’ load) 
(2) Separate power supply – Since amplification practically means boosting up the 
power of the signal, the circuit will need to be provided with an external power 
supply to generate this gain. 
(3) Fast response time – Although working with low frequencies, the signals was still 
quite complex. The circuit should be able to process signals at a fast rate so as to 
avoid any distortions. 
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After discussion from faculty members and colleagues in the NUS Department 
of Electrical and Computer Engineering and the Bioimaging Lab (Division of 
Bioengineering), it was decided that a simple current multiplier which uses operational 
amplifiers be designed. Since the setup needed to produce very high alternating 
currents (going up to 2.5 A), and was working at reasonably high voltages (around ±15 
V), the OPA548 High-Voltage, High-Current Operational Amplifier manufactured by 
Texas Instruments was used. 
This operational amplifier needed an external bipolar DC power supply. 
Therefore, the GPS-3303 manufactured by GwInstek was acquired. The power supply 
has the capacity to provide up to 3A current at an operational voltage of ±30V. A 
schematic of the amplification circuit is shown in Figure 3.4. Note that a gain of 3X on 
the current multiplier was chosen by setting the ratio 𝑅2 𝑅1� = 3000Ω1000Ω = 3 . 𝑅3  was 
placed to set a current limit as a safety measure. 
 





The circuit was first tested by making a temporary setup on a breadboard. It 
was immediately realised that overheating might cause the circuit to cease operation. 
To remedy this, a bigger passive heat sink was installed. Figure 3.5 shows a picture of 
the heat sink attached to the operational amplifier. After the installation, several 
successful trial runs were conducted with solenoids while the magnetic field produced 
was closely monitored. 
 
 
(a) Circuit board    (b) Heat sink 
 
(c) Assembled circuit 
Figure 3.5: Photographs showing the fabricated circuit board of the amplification 
circuit and how it is attached to the heat sink 
 
The fabrication was done at the PCB Fabrication Facility in the Department of 
Electrical and Computer Engineering. Multiple boards were fabricating using 
conventional photolithographic etching techniques. Holes were drilled to act as sockets 
for components by using computer controlled drilling machines. All the components 
which included secondary sockets, amplifiers and resistors were soldered on the PCB. 
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The final circuit was again tested several times before being used in any studies. An 
image of the completed circuit is included for reference in Figure 3.5(C). Note that 
output and input contacts from power supplies and waveform generators are fed in via 
crocodile clips clamped on the electrodes at the lower edge of the board. 
 
3.1.12 PEMF Stimulation Parameters 
The applied field consisted of electromagnetic pulses repeating at a frequency 
of 7.5Hz and a magnetic field strength of 1.8mT. The frequency and amplitude of the 
field produced by each stimulator unit was checked with an oscilloscope and magnetic 
field sensor probe during every medium change. The PEMF stimulation was turned on 
for a continuous 8 hours period and then off for 16 hours on each day. As shown in 
Figure 3.6, six solenoid coils were housed in a single incubator. Hence, the magnetic 
sensor probe was used to detect the presence of magnetic field outside the coils, so as 
to ensure no cross interference of magnetic fields between solenoids. To investigate 
the response of BMSCs under PEMF stimulation, the cultures were placed in the 
device and exposed to PEMF during the culture period. The cells were first seeded on 
day 0 and placed in an incubator overnight to allow cell attachment. On day 1, the 
cultures were then transferred into the PEMF setup where it would remain there till the 




(a)   (b)  
Figure 3.6: Photograph showing the positioning of six solenoids within the incubator 
(a) and the placement of culture well plates within the solenoid (b) 
 
3.1.13 Optimization of PEMF parameters 
An optimization study was done on the PEMF parameters to find out its effects 
on the osteogenesis of BMSCs. The parameters that were varied were exposure 
duration, frequency and magnetic flux density. The exposed groups were subjected to 
the parameters summarized in tables 3.1 to 3.3. The cells were cultured in well plates 












Table 3.1: Experimental parameters for variation of exposure duration 
Variation of Exposure Duration 
Group Exposure Duration 
Fixed Parameters 
Culture 
Medium Magnetic Flux 
Density 
Frequency 
A 2 hrs/day 
1.8 mT 8 Hz 
Osteogenic 
B 4 hrs/day Osteogenic 
C 12 hrs/day Osteogenic 
Control No PEMF No PEMF No PEMF Osteogenic 
 
Table 3.2: Experimental parameters for variation of frequency 








A 15 Hz 
1.8 mT 8 hrs/day 
Osteogenic 
B 25 Hz Osteogenic 
C 35 Hz Osteogenic 
Control No PEMF No PEMF No PEMF Non-Osteogenic 
 
Table 3.3: Experimental parameters for variation of magnetic flux density 
Variation of Magnetic flux density 
Group Magnetic Flux Density 
Fixed Parameters 
Culture 
Medium Frequency Exposure 
Duration 
A 3.6 mT 
8 Hz 8 hrs/day 
Osteogenic 
B 0.9 mT Osteogenic 
C 1.8 mT Osteogenic 
Control No PEMF No PEMF No PEMF Osteogenic 
 
3.1.14 Statistical analysis 
All data were presented as mean ± standard deviation. Multiple comparisons 
were performed using one-way analysis of variance (ANOVA) and posthoc Tukey 
tests. Pairwise comparisons were performed using two-tailed Student t-tests (SPSS 





3.2.1 Demonstration of osteogenic potential 
The proliferation of the BMSCs over 21 days of culture is shown in Figure 3.7. 
Overall, BMSCs in both groups proliferated over the culture period. The proliferation 
rate was higher in between day 7 and 14 (OST group: 3.2 fold from day 7 to 14, 1.2 
fold from day 14 to 21; CTRL group: 3.2 fold from day 7 to 14, 1.4 fold from day 14 
to 21). The slowdown in proliferation rate over the study period was likely due to the 
cells reaching confluence in the culture wells and also because BMSCs were moving 
from the proliferative phase into the differentiation and mineralization phase. The 
DNA content of samples in the OST group was significantly higher than the CTRL 
group across all time points.  
 
Figure 3.7: Pico green assay showing the proliferation of cells over a 21 day culture. 
Cells were shown to increase over time and the group cultured in osteogenic medium 
displayed higher proliferation than the group cultured in normal medium (#p < 0.05) 
 
The ALP activity of the BMSCs over the culture period is shown in Figure 3.8. 
The ALP activity of BMSCs cultured in osteogenic medium (OST group) increased 
from day 2 to 7, where it reached a peak and started dropping to lower levels at day 14 
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and 21. When the ALP activity was at its highest on day 7, the OST group had a 
significantly higher reading than the CTRL group. ALP is one of the markers used to 
track the development of osteoprogenitor cells toward their final fate. ALP is typically 
used in vitro to monitor the differentiation of MSCs towards the osteoblastic lineage. 
ALP elevates when MSCs begin to differentiate and has a peak around day 8, which 
coincides with their commitment to become osteoblasts [121]. Castano et al (2007) 
cultured rat MSCs in vitro for 16 days to monitor the ALP activity and calcium 
deposition [122]. It was reported that the ALP activity of MSCs cultured in osteogenic 
media increased from day 4 to day 10, where it reached a peak, and decreased 
thereafter [122], hence corroborating the results in this thesis.  
 
Figure 3.8: ALP activity normalized by the amount of DNA. ALP showed a rise 
between day 2 and 7, peaked at day 7 and followed by a drop in day 14 and 21. ALP in 
OST group was significantly higher than CTRL group in day 7 and 21. There was a 
sharp drop in ALP after day 7 (#p < 0.05) 
 
Calcium deposition was evaluated using a commercial kit based on the o-
cresolphthalein complexone (OCPC) method. The amount of calcium deposited was 
measured every 7 days and the results are shown in Figure 3.9. In the OST group 
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where the BMSCs were cultured in osteogenic medium, calcium was detected from 
day 7 and increased continuously until the last day of culture when it was last 
measured. No calcium was detected in the CTRL group, which contained BMSCs 
cultured in normal medium without osteogenic supplements. In a review article by 
Lian and Stein (1992), it was mentioned that initial amounts of calcium can be found 
as early as 6 to 8 days in MSCs cultured in osteogenic medium and they increase 
continuously after that. Extended mineralization implies the presence of mature 
osteoblasts [121]. As shown in Figure 3.9, calcium was detected in the OST group on 
day 7 and increased in subsequent days. The absence of calcium found in the CTRL 
group means that the BMSCs did not differentiate as there was no osteogenic stimulus. 
 
Figure 3.9: Measurement of calcium deposition in the samples. Osteogenic samples 
showed increasing amount of calcium deposited over time. Control samples did not 
show presence of calcium as the cells did not differentiate into osteoblasts. The 
increase in calcium was significant between day 7 and 14, but slowed down between 
day 14 and 21 (#p < 0.05) 
 
Gene expression levels of the osteogenic markers were evaluated every 7 days. 
The markers used were collagen type 1, runt-related transcription factor 2 (RUNX2) 
and osteopontin (OSP). Expression of RUNX2 in the OST group increased from day 7 
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to 14, peaked at day 14 and decreased thereafter. For the CTRL group, the expression 
of RUNX2 decreased continuously from day 7 to 21. For all three time points, RUNX2 
had a higher expression in the OST relative to CTRL. For collagen type 1 (COL1), the 
OST group also showed higher expression of this marker compared to the CTRL group 
at all time points. Expression of OSP was higher in the OST group compared to CTRL 
and peaked at day 14 of the study.  
 




 (B) Collagen type 1 
 
 (C) Osteopontin 
 
Figure 3.10: (A)-(C): Gene expression of osteogenic markers (#p < 0.05) 
 
Alizarin red staining was done on day 21 of the culture to detect for calcium 
deposition. A positive result for calcium is indicated by an orange red staining. 
Samples from the CTRL group showed no calcium deposition at all the time points. 
Samples from the OST group started to show obvious presence of calcium deposition 






Figure 3.11: Alizarin red staining of the samples on a weekly basis. The increasingly 
darker stains indicated greater calcium deposition over time. The control samples did 
not exhibit positive stain for calcium. 
 
3.2.2 Proof of concept of PEMF effects on BMSCs 
Cell counts in both the EMF and SHAM group increased over the 4 weeks’ 
culture. Cell population in the EMF group increased significantly from week 1 to 2 and 
stayed constant till the end of the culture. Cell population in the SHAM group also 
increased significantly from week 1 to 2, and the growth slowed from week 2 going 
into week 4. Under PEMF stimulation, the cell count in the EMF group was higher 
than the SHAM group at each time point, but the difference was not statistically 
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significant. The effect of PEMF stimulation seems to cause the cells to reach 
confluence more quickly. DNA content in the PEMF exposed group reached a plateau 
at week 4 and stayed constant till the end of study at week 4. Once the cells become 
confluent and start forming multi-layers, there was no significant difference in the 
DNA content between the control and the PEMF-exposed group until the end of the 
experiment. The lack of PEMF stimulatory effects on cell proliferation could be due to 
the cells going through the maturation process, i.e. undergoing differentiation and 
mineralization phases.  
 
Figure 3.12: Cell count of samples from the PEMF exposed group and the control 
group without exposure to PEMF 
 
The ALP activities of the BMSCs were measured for the BMSCs under PEMF 
stimulation and the sham exposed group. The ALP activity of the EMF group was 
higher than the SHAM group at every time point, but the increase was not significant. 
ALP is required during the mineralization process and it hydrolyzes phosphate 




Figure 3.13: ALP activity of samples from PEMF exposed samples and control 
samples without PEMF stimulation 
  
The calcium deposited by the cells was measured only at the week 3 and 4 time 
points. This was in part due to the limited amount of samples available for all the 
assays and also because the investigator estimates that mineralization process usually 
begins after the cells have differentiated. The calcium deposited by the EMF group 
was significantly higher than the SHAM group at both time points. This suggests that 
PEMF stimulation could cause the BMSCs to deposit more calcium. Sun et al (2009) 
also studied the effects of PEMF on the differentiation of human BMSCs and reported 




Figure 3.14: Comparison of calcium content measured from samples in the PEMF 
exposed group and the control group without PEMF stimulation (#p < 0.05) 
 
The collagen content secreted into the medium was measured on week 2 and 4. 
Under PEMF stimulation, the collagen secreted by the EMF group in week 2 and 4 
was higher than the SHAM group. Only the collagen secreted by EMF group in week 4 







Figure 3.15: Comparison of collagen formation measured from samples in the PEMF 
exposed group and control group without PEMF stimulation (#p < 0.05) 
 
In parallel with the findings from the calcium assay, Alizarin red staining of the 
samples at week 4 showed that the PEMF group exhibited greater mineralization than 
the SHAM group. 
 
(A)      (B)             
Figure 3.16: Alizarin red staining of calcium deposited by cells from the (A) PEMF 






3.2.3 Optimization of PEMF parameters 
Variation of exposure duration 
According to the ANOVA tests performed on the raw data, PEMF exposure 
was shown to have no significant impact on proliferation of BMSC during the 3-week 
culture period as shown in Figure 3.17. There was also no significant difference 
between the ALP activities of the cells from different groups as shown in Figure 3.18. 
 
Figure 3.17: Pico green assay showing the cell proliferation under different PEMF 
exposure duration for 3 weeks culture (8 Hz, 1.8 mT)  
 
Figure 3.18: ALP assay showing osteogenic differentiation activity under different 




Figure 3.19: Calcium assay showing mineralization of cells under different PEMF 
exposure duration for 3 weeks culture (8 Hz, 1.8 mT) 
 
The calcium deposition by different groups was recorded throughout the course 
of the experiment and the variation between different groups remained statistically 
insignificant as shown in Figure 3.19. 
 
Variation of frequency 
 
Figure 3.20: Pico green assay showing the cell proliferation under different PEMF 
frequencies for 3 weeks culture (8 h/day, 1.8 mT) 
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In Figure 3.20, the control group showed a gradual increase in cellular number 
over the course of study. The group exposed to the lowest frequency seemed to show 
enhanced proliferation during week two, while the group exposed to the intermediate 
frequency showed a plummet in cell count in the last week. 
 
Figure 3.21: ALP assay showing osteogenic differentiation activity under different 
PEMF frequencies for 3 weeks culture (8 h/day, 1.8 mT) 
 
The group exposed to the lowest frequency exhibited significantly higher ALP 
activity in the first two weeks. The control group had a lower activity during week one 





Figure 3.22: Calcium assay showing mineralization of cells under different PEMF 
frequencies for 3 weeks culture (8 h/day, 1.8 mT) 
 
The group exposed to the lowest frequency exhibited a higher calcium 
deposition throughout the study. The group exposed to the 25 Hz frequency had the 
lowest calcium deposition among the exposed samples as shown in Figure 3.22. 
 
Variation of magnetic flux density 
 
Figure 3.23: Pico green assay showing the cell proliferation under different PEMF 





At week 1, there was no significant difference in the DNA content from all 
groups. However, the ANOVA test confirmed that among the groups exposed to 
PEMF, groups exposed to lower strengths (0.9mT and 1.8mT) showed enhanced 
proliferation compared to highest field strength. The group that was not exposed to 
PEMF had a substantially low cell count in week 2 and week 3. 
 
 
Figure 3.24: ALP assay showing osteogenic differentiation activity under different 
PEMF magnetic flux densities for weeks 1 and 2 of culture (8 hr/day, 8 Hz) 
 
ALP activity, as in the previous study, did not provide a very good trend. 
However, substantial expression from all groups was indicated which confirmed 
osteogenic differentiation. Data was not collected for week 3 since samples were used 





Figure 3.25: Calcium assay showing mineralization of cells under different PEMF 
magnetic flux densities for weeks 1 and 2 of culture (8 hr/day, 8 Hz) 
 
All the groups exposed to PEMF showed a significantly higher calcium 
deposition by the end of week 1. However, groups exposed to lower field strengths 
(0.9mT and 1.8mT) performed marginally better in week 1. Data for week three was 
























Figure 3.26: Alizarin red staining from Week 1 and Week 3 
 
Since the extent of mineralization is fairly high in all groups. This has resulted 
in heavy stains being spread completely on the well surfaces. One aspect that should 
be appreciated in these images is that Alizarin Red had stained agglutinations 
indicating that the nodules have deposited mineralized content in them. 
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Figure 3.27: Light microscope images and corresponding DAPI images of the same 
location 
 
The staining proved that the nuclei from the osteoblasts and mesenchymal stem 
cells are showing expected morphology. There is sufficient number of viable cells in 
the culture, which are present even under the dark agglutinations. No florescence is 






3.3.1 Osteogenic potential of BMSCs 
BMSCs are a promising cell source for bone tissue engineering. It is known for 
its multi-potentiality by being able to differentiate into various cell lineages such as 
osteoblast, chondrocyte and adipocyte. It is also easily isolated due to its propensity to 
adhere to plastic walls of tissue culture plates. In vitro, it has been shown to proliferate 
and differentiate when suitable stimuli is applied. In order to provide sufficient number 
of cells for transplantation, in vitro expansion of BMSCs is an unavoidable part of 
bench side experiments, animal studies and clinical trials. This is especially so for 
bone tissue engineering studies whereby a high initial seeding density is desirable. 
Regardless of the seeding method used, a higher seeding density can be achieved with 
a higher inoculation of cell number. However, many studies have shown that the 
differentiation potential of MSCs decreases with increasing passage [123-125]. 
Furthermore, one study reported that the proliferation rate of rabbit BMSCs declined 
after several passages and cells entered a dormant phase, followed by a phase of 
immortal proliferation. Following immortalization, cells were unable to differentiate 
into adipocytes and chondrocytes [126].  
 
Therefore, an osteogenic differentiation study was done for the passage 3 rabbit 
BMSCs. Passage 3 was chosen because future studies required a large number of cells 
for seeding into scaffolds. At passage 3, the osteogenic differentiation ability of the 
BMSCs might be diminished. Hence, it was necessary to verify that the BMSCs were 
still differentiable. Differentiation of BMSCs into the osteogenic lineage required the 
use of an osteogenic supplemented (OS) medium which has been well documented. 
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Dexamethasone, L ascorbic acid and β-glycerophosphate are essential ingredients that 
will direct uncommitted BMSCs down the osteogenic lineage [127].  
 
Results from this study showed that the rabbit BMSCs were still able to 
differentiate into osteoblasts when cultured in OS medium. The addition of OS in the 
OST group caused the BMSCs to have higher proliferation over the CTRL group. The 
addition of OS also caused a significant increase in ALP activity per cell over time. 
This reflects the degree of progression of BMSCs into the osteoblastic lineage. ALP is 
a cell surface glycoprotein that is involved with mineralization and its expression is 
acquired during early differentiation [128]. As the BMSCs become osteoblasts, 
expression of Runx2 marker increased and peaked at day 14. Runx2 is a key 
transcription factor associated with osteoblast differentiation and is highly expressed in 
osteoblasts during development and after birth. Subsequent drop in ALP activity per 
cell correlates with advanced mineralization and terminal osteogenic cell 
differentiation as MSCs became osteocytes [127, 129].  
 
In this study, BMSCs differentiated into osteoblasts and started mineralizing at 
around day 7 of culture. The result from the calcium assay supported this as calcium 
was also detected at day 7 of culture. As the study progressed over time, BMSCs 
deposited more calcium and formed an extensive mineralized ECM over the surface of 
the culture plate, as shown by the Alizarin histology images. The expression of type I 
collagen was significantly higher in the OST group, indicating that ECM formation 
was occurring. Osteopontin expression was also higher in the OST group as compared 
to CTRL and it was upregulated in week 2 as the cells transited into mineralization 
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phase. Osteopontin, also known as bone sialoprotein, binds cell-surface integrin 
receptors, and regulates mineralization. It is expressed throughout matrix maturation.  
 
In this study, it was demonstrated that passage 3 BMSCs were able to 
differentiate into osteoblasts when osteogenic supplements were added to the culture 
medium. The assays (ALP and calcium content), gene expression studies and histology 
images showed that the cells displayed the phenotype of osteoblasts. Without 
osteogenic stimulation, BMSCs did not differentiate down the osteogenic lineage. 
Hence, BMSCs will be expanded in vitro till the third passage to be used in future 
studies, and the main reason is because of the limited number of rabbits available and 
that a large number of BMSCs is be required to achieve a high initial seeding density 
for bone tissue engineering studies.   
 
3.3.2 PEMF effects of BMSCs 
 In this study, cell counting of sample wells at week 1, 2 and 4 did not show an 
enhancement in proliferation of the PEMF exposed over the control group. The cell 
counts of the PEMF group were higher than the control at all time points, but not 
statistically significant. PEMF effects on cells are dependent upon many factors, one of 
which is the type of cells used. There are few published studies of PEMF stimulation 
on MSCs and they started appearing around 2008.  
 
In a study by Sun et al (2009), he seeded human BMSCs into six-well culture 
plates at an initial density of 3000 cells/cm2 [117]. He then monitored the proliferation 
of the cells over 7 days via detachment with trypsin and cell counting. Sun et al (2009) 
reported that exposure of BMSCs to PEMF increased cell proliferation by 29.6% 
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compared to untreated cells on day 1 of differentiation. As seen from Figure 3.17, 
which was taken from the paper, the up-regulating effects of PEMF on proliferation 
declined over the 7 day period. This suggested that PEMF effects on BMSCs probably 
manifested during early cell proliferation stage. It also explained why there were no 
significant differences in cell counts at week 1, 2 and 4 in this current study.     
 
Figure 3.28: Effect of PEMF exposure on cell proliferation. Cell populations were 
monitored over time, and data are presented as the relative ratio of PEMF-treated to 
untreated cell populations [117]  
 
In the current study, the ALP activity of MSCs under PEMF stimulation was 
higher than the control at both time points, but the difference was not statistically 
significant. ALP is considered to be an early marker of osteogenic differentiation and 
an increased activity indicates that MSCs are differentiating into osteoblasts. Studies 
have suggested that exposure of osteogenic cell lines to PEMF increases its ALP 
activity and led to a more differentiated and mature osteoblastic phenotype [99]. 
However, Schwartz et al (2008) cultured MSCs and found that PEMF did not provide 
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a stimulatory effect over that provided by the osteogenic medium [113]. Instead, 
Schwartz et al (2008) reported that PEMF synergizes with BMP-2 to increase ALP 
activity in MSCs during osteogenesis. These findings explain the absence of a marked 
increase in ALP activity in the PEMF exposed group for the current study. 
 
In the current study, PEMF stimulation was shown to enhance the formation of 
mineralized ECM. The calcium content measured in the PEMF exposed samples at 
week 3 and 4 was significantly higher than the control samples. The collagen content 
in the PEMF exposed samples at week 4 was also significantly higher than the control 
samples. The alizarin red staining of samples at week 4 showed heavier staining of 
calcium deposits in the PEMF exposed samples compared to control samples. This is 
in agreement with Sun et al (2009) who demonstrated using Von Kossa staining at day 
0, 3, 7 and 11 that PEMF enhanced mineralization near the midpoint of osteogenesis. 
The enhanced ALP activity in the PEMF exposed samples was likely to have 
contributed to this enhanced mineralization. This is because ALP is needed during the 
mineralization process and hydrolyzes phosphate-containing substrates to increase the 
local phosphate concentration. 
 
3.3.3 Optimization of PEMF parameters 
3.3.3.1 Exposure duration variation 
For the experiment on variation of exposure duration, it seems that varying the 
PEMF exposure duration throughout the course of the experiment had no impact on 
proliferation, differentiation or mineralization of BMSCs. This observation can be due 
to a variety of reasons, but the foremost seems to be associated with the batch of cells 
used. In subsequent experiments, the application of PEMF on cells from different 
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batches did produce enhanced mineralization and proliferation profiles. At the same 
time, it was also observed that changing cell batches affected the absolute amount of 
DNA content, ALP activity and calcium deposition. These fluctuations in measured 
quantities can only be attributed to the variation in cell performance from different 
batches as all other culture parameters were kept constant, especially for the controls. 
ALP activity was quite prominent indicating that the cells were differentiating under 
the culture conditions provided. Since ALP is an early marker of differentiation[130], 
it can be expected that the values will fall after 7-10 days of culturing. Mineralization 
which was measured with respect to the amount of calcium deposited by the cells 
showed an increasing trend which was expected. 
 
3.3.3.2 Frequency variation 
For the experiment on frequency variation, data from proliferation, ALP and 
calcium assays suggests that groups exposed to different frequencies did experience 
different proliferation and differentiation rates. The group exposed to the lowest 
frequency of 15 Hz showed enhanced proliferation, differentiation and mineralization 
at most points during thez study, especially during the during the first 2 weeks of 
culturing. This finding is in line with the study conducted by Sun et al [131]. who have 
used very similar parameters in their study (frequency of 15 Hz, same exposure 
duration and magnetic flux density). Their study only lasted for 1.5 weeks and in 
which they recorded an increasing proliferation, differentiation and mineralization 
trend.  
 
Looking at the proliferation data from the study, it was observed that cells 
exposed to osteogenic medium exhibited enhanced proliferation compared to the 
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control group. However, the DNA concentration kept fluctuating, and for some groups, 
even decreased as the study progressed. The DNA concentration for the control with 
non-osteogenic medium kept on increasing. This re-assures our assumption that 
fluctuations in cell number in this study and the previous study may be attributed to 
osteogenic differentiation in general. 
ALP activity by cells showed that MSCs were differentiating into osteoblasts. 
It was noted that in week 2, the group which was not exposed to osteogenic medium 
did exhibit ALP activity. However, since the calcium deposition for this group 
remained zero throughout the experiment, it can be safely assumed that no 
differentiation took place in the control group. Calcium detection assays have provided 
substantial evidence to support the hypothesis that altering frequency affects 
osteogenic differentiation of cell. Mineralization in all groups kept on increasing 
throughout the study for all groups that were cultured in osteogenic medium. 
 
3.3.3.3 Magnetic flux density variation 
Looking at the data from Pico Green assays and calcium deposition, it can be 
seen that lower magnetic field strengths showed higher cell numbers and slightly better 
mineralization compared to other groups during the initial phase of the study. From the 
DAPI staining, it was observed that nuclei are aligned and stretched into an oval shape 
which shows that the cells are in a spindle like formation. This cellular conformation 
confirms that the cells are adhered to the surface of the well plate which is necessary 
for their survival. Living cells were spotted under the dark agglutinations which 





More importantly, DNA cannot be seen from any other organism in the 
fluorescent images even at high magnifications. This proves that the cell culture was 
not contaminated. As a precaution, FDA staining was done on aspirated medium from 
the wells and no staining was observed, which is in line with the findings from the 
DAPI staining. Another discovery made about the agglutinations came from Alizarin 
red staining. High calcium content was found in these agglutinations, which suggested 
that these bodies were actually “bone nodules”. Formation of bone nodules is a 
characteristic of osteogenic differentiation[132]. In several studies these nodules are 
made more prominent by von-Kossa stains and then counted in order to gauge 
osteogenic differentiation[133-135]. 
 
It is known that formation of bone nodules causes cells to detach or delaminate 
from the adhesion surface. This detachment can be highly variable, since different 
surfaces respond differently to mineralization[136]. However, this phenomenon 
explains why DNA content in the cultures exposed to osteogenic medium kept on 
decreasing as studies progressed. Excessive mineral deposition in the small 2 cm2 area 
of the 24-well culture plate may have forced cells to peel off.  
 
3.4 Concluding remarks 
The study of PEMF stimulation on MSCs in a two dimensional (2D) culture model 
was done in this stage of the study. Rabbit BMSC was identified as the source of stem 
cells to be used in this project. MSCs demonstrated its ability to differentiate down the 
osteogenic lineage. A PEMF apparatus was built and used to provide stimulation to 
MSCs cultured in well plates. Exposure to PEMF was shown to enhance the 





Stage II: Development of a scaffold for bone tissue engineering 
 
4.1 Materials and Methods 
4.1.1 Design of scaffold  
 The first prototype of the scaffold was shown in Figure 4.1. The initial concept 
was to fabricate a cylindrical shaped scaffold with dimension 17 mm diameter and 3 
mm thickness. The size of the scaffold would allow for cultivation of large tissue 
engineered constructs. As the dimensions were large, features were added into the 
design to facilitate its subsequent placement inside a bioreactor chamber. The pair of 
polycarbonate rings served as anchor for the scaffold material. Silk thread was knitted 
to form a net, sandwiched together using two polycarbonate rings (Figure 4.1B). The 
rings with silk netting were placed in a mold and silk solution was injected into the 
mold. The mold was frozen at -20oC and freeze dried to form porous scaffold. With 
this design, multiple scaffolds could be stacked and cultivated in a single bioreactor 
chamber neatly.  
 
  
(A)                       (B) 
Figure 4.1: Photograph showing the (A) first prototype of the scaffold and (B) the 
template mold used to contain the silk solution   
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 The first prototype was later revised as the scaffold dimensions were too big 
and a large number of cells were required to achieve a high initial cell seeding density. 
For the second prototype, the size of the cylindrical scaffold was reduced to 5 mm 
diameter and 5 mm thick. This was achieved by using a biopsy punch with a 5 mm 
diameter. The polycarbonate rings were also excluded in the revised design. Lesser 
cells were needed to achieve a high seeding density and more scaffolds could be 
seeded to get a better sample size for statistical analysis.   
 
4.1.2 Silk scaffold fabrication 
Raw B. mori silk fibers (local name “Nang Lai” silk fibers) were used to 
fabricate the silk sponge scaffolds. The raw silk fibers were first immersed in a 
degumming solution, which comprised of 0.25% (w/v) Na2CO3 and 0.25% (w/v) 
sodium dodecyl sulfate, heated till 98 to 100oC. The used degumming solution had to 
be replaced with fresh solution after 45 minutes. This cycle was repeated until most of 
the sericin protein had been removed. The degummed silk fibers were then rinsed with 
distilled water to remove any residual degumming solution. The degummed silk fibers 
were dried in a vacuum oven.  
 
Next, aqueous silk solution was prepared by dissolving the dried silk fibers in a 
ternary solvent (CaCl2 – CH3CH2OH – H2O, mole ratio = 1:2:8) at 65 to 70oC with 
continuous stirring. The prepared silk solution was dialyzed against distilled water 
using a Snakeskin Pleated Dialysis Tubing (PIERCE, MWCO 3500). The 
concentration of the silk solution was determined post-dialysis by drying 100µl of 
solution on a cover slip and weighing the residual silk on an analytical balance 
(Mettler Toledo). The silk solution was diluted to a final concentration of 3% (w/v) 
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with distilled water and added into a Petri dish. The silk solution was frozen at -20oC 
for 4 hours and freeze-dried for 20 hours to allow the formation of porous silk sponges. 
The freeze dried silk sponges were subsequently treated in a 90/10 (v/v) 
methanol/water solution for 30 minutes to induce conformational change from 
amorphous silk to silk II, so as to prevent the sponge from dissolving in the cell culture 
medium. The treated silk sponges were freeze dried again for 24 hours to remove the 
water content. Finally, a biopsy punch was used to create many cylindrically shaped 




(A)   (B) 
  
(C)            (D) 
  
(E)   (F) 
Figure 4.2: Steps in fabricating silk sponge scaffolds starting from (A) raw silk fibers 
to (B) degummed silk fibers. (C) Silk fibers were dissolved in a ternary solvent (D) 
Silk solution was dialyzed in distilled water. (E) Silk solution was cast into molds or 
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Petri dishes and freeze dried. The freeze dried silk sponge was treated with methanol, 
freeze dried again and cut using a dermal punch to form (F) cylindrical silk sponge 
scaffolds 
 
4.1.3 Optimization of silk scaffold protocol 
 Before the silk scaffold could be used for cell seeding studies, its properties 
have to be optimized. These include the porosity, average pore size and the general 
morphology of the pore architecture. Using the freeze drying method, the 
aforementioned properties are controlled by the concentration (w/v) of silk solution 
used. Generally, a higher silk concentration leads to smaller pore sizes and lower 
porosity. For this optimization study, silk solution with concentrations of 2%, 3% and 
4% were prepared and freeze-dried to form sponges. Samples from each group were 
scanned using SEM to observe the pore morphology and measure the average pore 
sizes. 
 
4.1.4 Scanning electron microscopy 
 Scanning electron microscopy was used to observe the morphology and 
determine the pore size of the scaffold. The scaffold samples were sputter-coated with 
gold and observed using SEM (JSM-5800LV, JEOL, Tokyo, Japan). Diameter and 
pore size distribution of the sponge scaffold were measured from the SEM images with 
Image J, an image processing program. 
 
4.1.5 Porosity 
Mercury intrusion porosimetry was used to measure the porosity of the silk 
sponge scaffolds. The test was carried out using the mercury porosimeter (Autopore IV, 
Micromeritics) from the Structural Engineering Laboratory with the assistance of the 
laboratory officer. The sample scaffolds, measuring 5 mm diameter and 5 mm thick, 
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were weighed and placed inside a penetrometer. The penetrometer containing the 
sample was filled with mercury at increasing amount of pressure, up to 60,000 psi. By 
measuring the change in intrusion volume of mercury into the sample, the equipment’s 
software was able to calculate the porosity of the sample. 
 
4.1.6 Static seeding technique 
The scaffolds were first sterilized by autoclaving at 121oC and dried in the 
vacuum oven. BMSCs from passage three were used for seeding onto the scaffolds. 
The cells were harvested via trypsin treatment and counted using a hemocytometer. 
The seeding density was 106 cells per scaffold. Prior to seeding, the scaffolds were pre-
wet with culture medium and then blot dry using sterile filter paper. 40 μL of cell 
suspension containing 106 cells were pipetted onto each scaffold. Due to the sponge 
nature of the scaffold, the cell suspension was readily absorbed into the scaffold. The 
seeded scaffold construct was placed in the incubator at 370C, 5% CO2 for 3 hours to 
allow cell attachment. After that, the well containing the cell-seeded construct was 







(C) (D)  
Figure 4.3: Steps in static seeding. (A) Dry scaffold, (B) Scaffold wet with medium, (C) 
Scaffold was blotted dry using sterile filter paper. (D) Seeding with pipette 
 
4.1.7 In vitro study 
4.1.7.1 Silk scaffolds 
The BMSC-seeded scaffolds were cultured in-vitro in non-treated 24-well 
plates. The osteogenic (OST) group was cultured using differentiation medium which 
consisted of high glucose DMEM supplemented with 15% FBS (HyClone, Logan, UT) 
and 1% antibiotics (200 units/ml penicillin G and 200 units/ml streptomycin sulfate), 
10 nM dexamethasone (Sigma), 50μg/ml L-ascorbic acid, and 10 mM β-
glycerophosphate. The control group was cultured in normal medium which consisted 
of low glucose DMEM (Gibco, Invitrogen, CA) supplemented with 15% FBS and 1% 
antibiotics. Both groups were maintained in the incubator at 37oC and 5% humidified 
CO2 over a period of 3 weeks. Media change was done every 3 days. Samples (n = 3) 
were taken at weekly time points (week 1, 2 and 3) to assess for the proliferation, 
differentiation, calcium deposition and osteogenic gene expression levels. Histological 
staining, namely hematoxylin and eosin (H&E) and Alizarin Red, was performed at the 
week 3 time point. 
 
4.1.7.2 Silk Scaffold with PEMF stimulation 
The silk scaffolds were seeded with BMSCs from the third passage at a density 
of 106 cells per scaffold. The static seeding technique was used and three hours post 
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seeding, 1 ml of culture medium was added to the cell-seeded construct. Twenty four 
hours after seeding, the well plates containing the PEMF exposed group were 
transferred to the PEMF setup. The PEMF setup with the well plates is shown in 
Figure 4.4. The control group was not exposed to PEMF stimulation and was placed in 
a separate incubator. Both groups were cultured using OS medium containing high 
glucose DMEM supplemented with 15% FBS (HyClone, Logan, UT) and 1% 
antibiotics (200 units/ml penicillin G and 200 units/ml streptomycin sulfate), 10 nM 
dexamethasone (Sigma), 50μg/ml L-ascorbic acid, and 10 mM β-glycerophosphate. 
Both groups were maintained in the incubator at 37oC and 5% humidified CO2 over a 
period of 3 weeks. Media change was done every 3 days. After loading in the samples, 
the setup was allowed to run without disturbances such as opening/closing of the 
incubator. The frequency and amplitude of the magnetic field was checked once every 
two days during medium change for the samples. Samples were taken at weekly time 









4.1.8 Cell seeding efficiency and Cell attachment observation 
 Three hours after the scaffolds were seeded with cells, the scaffolds were 
transferred to new wells and the medium in the original wells was collected into 
separate micro-centrifuge tubes. Cell counts were performed on each of these tubes as 
they contained cells that did not attach onto the scaffold during seeding. The seeding 
efficiency was calculated by finding the percentage of the number of cells attached 
onto the scaffold over the number of cells seeded per scaffold.  
 
Live cell staining was also done 24 hours after seeding to observe the viability 
and distribution of the seeded cells on the scaffold. The sample was washed with PBS 
and cut into 4 sections along the sagittal plane, as illustrated in Figure 4.5. The sections 
were incubated in 1 ml of medium containing 5 mg/ml fluorescein diacetate (FDA) 
dye for 3 minutes at room temperature. The stained sections were then rinsed with PBS 
and 1 ml of PBS was added to keep the sections wet. The sections were examined 
using an inverted fluorescence microscope (IX71 Inverted Research Microscope, 
Olympus) under blue excitation.  
  
(a)                                               (b) 
Figure 4.5: Schematic showing how the scaffold was sectioned in the sagittal direction. 
(a) The scaffold represented by the yellow cylinder was cut into 4 sections. The two in 
the central region were labeled as MID while the two at the sides were labeled SIDE. 
(b) An example of how a section looks like. The green spots represent the cells when 




4.1.9 Pico green assay 
Samples (n = 3) from each group were collected at weekly time points to assess 
cell proliferation. The cell-seeded scaffolds were rinsed with ice-cold water to remove 
traces of culture medium, transferred into cryovials and stored in a liquid nitrogen tank. 
Analysis of samples was performed together after samples from all time points were 
harvested, so as to ensure consistency. Prior to analysis using PicoGreen, the samples 
were freeze dried to ensure no water in the samples. Different water content would 
interfere with the DNA concentration and hence the Pico Green results.  
 
The measurement of the cell number in each well was assessed using the 
Quant-iT Pico Green dsDNA reagent kit (Invitrogen), which is an ultrasensitive 
fluorescent nucleic acid stain for quantitating double-stranded DNA in solution. The 
freeze dried samples were broken up into powder using a pipette tip and treated with 
Buffer RLT Qiagen) cell lysis buffer. The cell lysate was homogenized via repeated 
pipetting. A fresh tip was used for each sample and care was taken to try and minimize 
the loss of homogenate. The tubes were vortexed for 5 minutes and then centrifuged at 
16,000 rpm for 5 minutes. 20 µL of cell lysate was mixed with 80 µL of PicoGreen 
dye, prepared based on the manufacturer’s protocol, in 96-well black plates. 
Fluorescence intensity was measured using a FLUOstar Optima fluorescent plate 
reader (BMG Labtech, Offenburg, Germany) at 520 nm wavelength after excitation at 
485 nm, using a gain of 1000, 10 flashes per well and a position delay time of 0.2 to 
0.5s. The relative fluorescence unit value read using the machine was compared 





4.1.10 ALP assay 
To assess the osteogenic differentiation of the cells, ALP activity of the 
samples (n = 3) were measured using the Phosphatase Substrate Kit (PIERCE). 
Samples were first washed with PBS, and then incubated with 1000 µL solution of 
para-nitrophenyl phosphate (pnPP) disodium salt in Diethanolamine Substrate Buffer 
(1mg/ml) for 1 hour in a humidified atmosphere of 5% CO2 at 370C. After 1 hour, 500 
µL of 2N sodium hydroxide was added to stop the reaction. The absorbance values 
were measured at 405 nm immediately using a microplate reader. The ALP activity 
was calculated using the formula given by the manufacturer.  
 
4.1.11 Calcium content assay 
To measure the amount of calcium deposited during osteogenesis, a 
colorimetric assay based on the calcium O-cresolphthalein complexone methodology 
was carried out using the Calcium (CPC) LiquiColor test (Stanbio Laboratory, TX). 
Samples (n = 3 per group) were first washed with PBS and then incubated with 500 µL 
of 5% trichloroacetic acid (TCA) at room temperature for 30 minutes. The samples 
were transferred to a micro-centrifuge tube and centrifuged at 16,000 rpm for 5 
minutes to sediment the cell debris. 30 µL of each sample was added to 300 µL of the 
working reagent. Aliquots of 100 µL were pipetted in triplicates into 96-well plates. 
Absorbance values were measured at 575nm using a microplate reader. A standard 
curve was done using the calcium standards provided by the manufacturer and the 
absorbance readings of the samples were read off the standard cure to obtain the 






To examine the expression of osteogenic-related genes at different time points, 
mRNA expressions levels of Runx2/Cbfa-1, collagen type I and osteopontin were 
determined using real time quantitative polymerase chain reaction (RT-PCR). Cell-
seeded scaffolds (n = 3) were rinsed with ice-cold PBS, transferred into 2 ml plastic 
tubes and 1.0 ml of Trizol reagent (Invitrogen) was added. The tubes were vortexed for 
5 minutes and centrifuged at 14680 rpm for 10 minutes. The supernatant was 
transferred to a new tube and 200 μl of chlorofoam was added to the solution. The 
mixture was allowed to stand for 5 minutes at room temperature, after which it was 
centrifuged again at 14680 rpm for 15 minutes. The upper aqueous phase was 
transferred to a new tube where one volume of 70% ethanol (v/v) was added and 
applied to an RNeasy Mini Kit (Qiagen, Hilden, Germany). The RNA was washed and 
eluted following the manufacturer’s protocol. The RNA concentration was measured 
using a spectrophotometer (Nanodrop 2000c, Thermo Scientific). RNA was reverse-
transcribed in cDNA according to the manufacturer’s protocol (iScript cDNA synthesis 
kit, BioRad Laboratories, CA). RT-PCR was done using the iQTM SYBR Green 
Supermix (Bio-Rad Laboratories, CA). The PCR system comprised of 12.5 µL SYBR 
Green dye, 4 µL of cDNA, 5 µL of primer with the optimal concentration and topped 
up to 25 µL with nuclease-free water. All reactions were performed on the iQ5 Multi 
Colour Real-Time PCR detection system. The level of expression of the target gene 









Samples for histology were fixed in 3.7% formaldehyde for 24 hours, 
dehydrated and then paraffin-embedded. 10µm paraffin sections were cut with a rotary 
microtome (Leica Biosystems) and stained with hematoxylin and eosin (H&E) 
according to routine histology protocol (Appendix B). Von Kossa staining was also 
done according to routine protocol to detect presence of calcium. 
  
4.1.14 Statistical analysis 
All data were presented as mean ± standard deviation. Multiple comparisons 
were performed using one-way ANOVA and posthoc Tukey tests. Pairwise 
comparisons were performed using two-tailed Student t-tests (SPSS 13.0 software 
package). p<0.05 was accepted as statistically significant. 
 
4.2 Results  
4.2.1 Scanning electron microscopy 
Figure 4.6 shows the SEM observation of the silk sponge’s porous architecture. 
Figures 4.6(A)-(C) show the morphology of silk scaffolds with 2%, 3% and 4% 
concentration respectively. At 2% and 3% concentration, the scaffolds looked highly 
porous, whereas at 4% concentration, the number of pores started decreasing and 
occlusion of pores at the surface was observed. A concentration of 3% was deemed 
more suitable than 2% because when the sponges were immersed in PBS solution, the 
2% silk scaffolds were unable to maintain its cylindrical shape and collapsed. This did 




From Figure 4.6(B) and (D), the general morphology of the 3% silk scaffold 
showed that the pores were quite homogenous in terms of shape and size. Average 
pore size was measured using the Image J software and is 311 ± 24 µm. The pore 
architecture appeared uniform and the shape of the pores are generally equiaxed. The 
close-up image in 4.6(D) showed that the pores in 3% silk scaffolds were highly 
interconnected as the pores on the surface could be seen opening up to those deeper in 
the interior. Figure 4.6(E) showed a transverse section of the middle region of the 
cylindrical scaffold stained with eosin dye. The scaffold fibers formed an 
interconnected network of pores that opened up to one another.    
 
Figure 4.6(F) shows the morphology of a poorly fabricated scaffold, in which 
the pores are irregular in size and elongated. The reason for this is due to the freezing 










(A)      (B) 
  
(C)      (D) 
  
(E)      (F) 
 
Figure 4.6: SEM images showing surface morphology of (A) 2% silk (B) 3% silk and 
(C) 4% silk. (D) Close-up view of the 3% silk scaffold. (E) Histological section of the 
middle region of the scaffold. Pores open up to one another and are interconnected. (F) 





4.2.2 Mercury Porosimetry  
The porosity of the silk scaffolds was measured using the mercury porosimeter 
and found to be 75.7 ± 6.3%.  
 
4.2.3 Cell seeding efficiency and Cell attachment study 
 The seeding efficiency of the static seeding method was taken from 5 scaffold 
samples and was found to be 89.0 ± 6.4%. The cell attachment was evaluated using 
FDA staining on sectioned parts of the cell seeded scaffold. Figure 4.7 shows the 
distribution of cells which attached onto the scaffolds 24 hours after seeding. Using the 
static seeding method, cells were mostly attached to the periphery of the scaffold as 
expected. There was little penetration of the cells into the scaffold interior. 
 
Figure 4.7: FDA staining showing the distribution of cells after seeding. Cells were 
concentrated at the periphery of the scaffold 
 
4.2.4 In-vitro study 
4.2.4.1 Silk sponge scaffold 
The DNA content of the cell-seeded constructs for both groups are shown in 
Figure 4.8 below. DNA content in the CTRL group showed a slight decreasing trend 
over the 3 weeks, which suggested that some of the seeded cells might have died. On 
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the other hand, DNA contents in the OST samples are higher than the CTRL samples 
and it stayed relatively constant throughout the period of study.  
 
Figure 4.8: Pico green assay measuring DNA content of silk sponge scaffolds cultured 
in osteogenic medium and control medium (#p < 0.05) 
 
 The ALP activities of the cell-seeded constructs are shown in Figure 4.9. ALP 
activity in the OST group was higher than the CTRL group at all time points. Like in 
the 2D study, ALP activity reached a peak and then started to decline. The activities 




Figure 4.9: ALP activity of 3D constructs cultured in osteogenic medium and normal 
medium over 3 weeks (#p < 0.05) 
  
The results of the calcium content measurement are shown in Figure 4.10. 
Calcium content in the OST group was significantly higher than the CTRL group at all 
time points. Calcium deposition was found in the OST group as early as week 1 and 
showed an increasing trend over the three weeks. CTRL group had little or no calcium 
deposition as there was no osteogenic stimulus introduced. H&E and Von Kossa 
staining were done on the samples at week 3 of the study (Figure 4.12). H&E showed 
that cells were attached onto scaffold fibers with normal morphology. Von Kossa 
staining showed presence of dark deposits, indicative of calcium in OST samples while 




Figure 4.10: Calcium content assay showing the deposition of calcium when silk 
sponge scaffolds were cultured in osteogenic and normal medium (#p < 0.05) 
 
Gene expression of RUNX2 in OST group was significantly higher than CTRL 
group in week 1 and 2.  The highest level of RUNX2 expression was detected in week 
1 and the levels declined over the weeks. Collagen type I expression was significantly 
higher in the OST group and the expression levels showed a gentle decline over the 
weeks. Osteopontin expression was generally higher in the OST group, peaking at 




 (A) RUNX2 transcription factor 
 




 (C) Osteopontin 
 
Figure 4.11: Gene expression of osteogenic markers when the constructs were cultured 














(A)      (B) 
 
(C)      (D) 
 
(E)      (F) 
Figure 4.12: Histological staining of scaffolds. (B), (D) and (F) are the zoom in images 
of (A), (C) and (E). (A) H&E staining of silk sponge scaffold at week 3 of culture. 
Cells were well attached to scaffold fibers. (C) Von Kossa staining of constructs 
cultured in osteogenic medium showed dark deposits of calcium. (E) Von Kossa 







4.2.4.2 3D PEMF Study 
 The DNA content of the samples in EMF and SHAM groups were measured 
using Pico Green assay and the results are as shown in Figure 4.13. Cells in both 
groups proliferated over the 3 weeks, as shown by the trend of increasing DNA content. 
There was no significant difference between the EMF and SHAM group at each time 
point.  
 
Figure 4.13: Pico green assay measuring DNA content of silk sponge scaffolds 
cultured in osteogenic medium, with the EMF group exposed to PEMF stimulation and 











 The ALP activities of the EMF and SHAM groups are shown in Figure 4.14. 
ALP activity peaked at week 1 and decreased in the subsequent weeks. 
 
Figure 4.14: ALP activity of 3D constructs cultured in osteogenic medium, with the 
EMF group exposed to PEMF stimulation and the SHAM group without PEMF 
stimulation (#p < 0.05) 
  
The calcium content for the EMF study on 3D scaffolds is as shown in Figure 
4.15. Calcium deposition started at early as week 1 and increased over time. There was 
a dip in the calcium measured in the SHAM group at week 2. This was likely due to 
fragments of scaffolds breaking off from the main body during handling. The calcium 
content of the EMF group was higher than the SHAM group at all three time points. At 
the end of the culture, the amount of calcium measured in the EMF samples was 2.1 




Figure 4.15: Calcium content assay showing the deposition of calcium when silk 
sponge scaffolds were cultured in osteogenic medium, with the EMF group exposed to 
PEMF stimulation and the SHAM group without PEMF stimulation (#p < 0.05) 
 
4.3 Discussion 
4.3.1 Optimization of scaffold architecture 
In this study, a scaffold was designed and fabricated for use in bone tissue 
engineering application. Silk fibroin from B mori silkworm was the material of choice 
and freeze drying process was used to create the porous structure within the scaffold. 
To create a scaffold with homogenous architecture, optimization was performed for the 
fabrication process.  
 
The rationale for fine tuning the scaffold architecture is because the 3D 
structure of the scaffold has been shown to influence cellular activity. Scaffold pore 
size has been found to influence adhesion, growth and phenotype of a wide variety of 
cell types such as fibroblasts, osteoblasts, rat marrow cells and chondrocytes [137]. 
Optimal pore sizes allow maximal infiltration of cells into the interior and cell 
adhesion. For bone tissue engineering, the preferred pore size ranges from 100 to 500 
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µm for in vitro culture [30]. For adequate mass transport within a thick engineered 
tissue, the minimum pore size should be 300 µm [31]. The size of the pores is 
determined by the concentration of silk solution used. Pore size created is inversely 
proportional to the concentration of silk used. As the pore size increases, mechanical 
property of the scaffold will get weaker. Pores of a mechanically weak scaffold will 
collapse upon itself when it is wet. Hence, there has to be a balance between the pore 
size and mechanical properties. 
 
In this study, the pore size was optimized by experimenting with silk 
concentrations of 2%, 3% and 4%. The SEM images showed that 3% is a suitable 
concentration to use for future fabrication of silk sponges. At 3%, the average pore size 
of 311 µm is above the minimum target pore size set for this study. Pores appeared 
approximately equiaxed with little variation in size. Silk concentration of 4% resulted 
in pores that were smaller than the minimum pore size. From the image, pore 
distribution was not as good as the 3% samples and occlusion of pores was observed 
on several areas of the scaffold. Such a pore structure would impede cell infiltration 
into the interior of the scaffold and hence proper development of the tissue engineered 
construct. For the 2% concentration, the pores look well distributed but when the 
scaffold was put inside medium, it became soft to handle with a forceps and was 
unable to maintain its structural integrity. Pores collapsed and closed unto themselves, 
making it difficult to allow proper cell infiltration. Therefore, a silk concentration of 3% 
proved to be most suitable for cell cultivation and tissue engineering application.  
 
Zeltinger et al (2001) showed that if the scaffold architecture is heterogeneous, 
it would result in variable cell adhesion and also affect the ability of the cell to produce 
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a uniform distribution of ECM proteins [138]. In addition, the tissue generated from a 
scaffold with non-uniform architecture would have inferior biomechanical properties 
compared to one formed from a scaffold with a more uniform structure [139].  
 
To achieve a homogenous architecture using the freeze drying process, the 
freezing rate of the silk solution has to be controlled. During the process of freezing 
silk solution, a continuous and interpenetrating network of ice crystals forms between 
the frozen silk. Sublimation of the ice crystals creates a highly porous silk sponge 
scaffold. The appearance of the pore structure depends greatly on the freezing 
processes during fabrication. When the silk solution was put into the -80oC freezer, the 
rapid uncontrolled quench freezing resulted in space- and time- variable transfer of 
heat throughout the silk solution. There was non-uniform nucleation and growth of ice 
crystals which, after sublimation, created heterogeneous pore structure. O’Brien et al 
(2003) studied the effect of freezing rate on pore structures in freeze-dried collagen-
GAG scaffolds and he found that a constant cooling rate of 0.9oC/min produced more 
homogenous scaffolds [137].  
 
To overcome this problem, a better freeze drying machine (Martin Christ, 
Epsilon 1-4 LSC, Germany) was procured and it has the ability to freeze samples down 
to -20oC at a rate controlled by the user. The slower and constant cooling rate creates a 
more uniform temperature distribution throughout the silk solution in the Petri dish, 
resulting in a more consistent ice crystal nucleation and growth. In this study, with a 
constant rate of cooling technique rather than a quenching technique to freeze the silk 
solution prior to sublimation, scaffold pores became more equiaxed and there was no 
significant pore size variation throughout the scaffold.  
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4.3.2 Static cell seeding 
The seeding efficiency of the direct pipetting method was quite high, around 
89%. Most of the cells that were added attached onto the silk material. However, 
seeding of cells via direct pipetting of cell suspension did not result in a good 
distribution of cells throughout the entire scaffold. From the micrographs, it was 
shown that the cells were mostly attached to the periphery of the scaffold with little 
infiltration. As the regeneration of tissue is not homogenous throughout the entire 
scaffold, this would ultimately affect the functionality of the tissue engineered graft, 
resulting in inferior constructs. One of the solutions would be to use better seeding 
techniques such as dynamic seeding. Dynamic seeding involves the movement of cell 
suspension through and around the scaffold. Studies have shown that it provides better 
seeding outcomes and growth than static seeding [140, 141]. 
 
4.3.3 In vitro study 
4.3.3.1 Silk scaffold (OST versus CTRL) 
In this study, BMSCs were seeded via direct pipetting of the cell suspension 
onto the silk scaffolds. The cell seeded constructs were cultured for 3 weeks under 
static conditions and the progress of osteogenesis was tracked. The same amount of 
cells was seeded for both osteogenic and control group. By the end of week one, the 
DNA content in the osteogenic samples were significantly higher than the control 
samples. The osteogenic group was exposed to the differentiation medium from the 
start, and the growth factors in the culture medium promoted the proliferation of cells 
seeded in the scaffolds. After week one, the number of cells in both groups was 




The utilization of MSCs for bone tissue engineering requires differentiation 
into bone-forming osteoblasts. This differentiation is accompanied by an increase in 
the expression and activity of the enzyme ALP, and enhanced expression and secretion 
of the proteins of the ECM and the mineralization of the ECM to form calcified bone 
tissue.  
 
Differentiation of BMSCs occurred between weeks one to two of the culture 
period. As the cells transited from the proliferation to differentiation phase, the DNA 
content stopped increasing. At the same time, the ALP activity of the osteogenic group 
was significantly higher than the control group at all time points and peaked at week 
two. Reported effects of osteogenic factors (dexamethasone, β-glycerophosphate and 
L-ascorbic 2-phosphate) are an increase of ALP activity, mineral deposition and no 
osteocalcin expression [127]. The ALP results demonstrated that BMSCs in the 
osteogenic group have undergone differentiation into osteoblasts. From the RT-PCR 
results, expression of Runx-2 in the osteogenic group was the highest at week one and 
decreased over the culture period. Runx-2 expression in the control group was 
markedly lower at all time points. Runx-2 is a key transcription factor associated with 
the regulation of osteoblast differentiation. Its high expression in the early phase of the 
study indicates that the BMSCs are undergoing differentiation into osteoblasts.  
 
As the study progressed into week three, the ALP activity saw a drop from its 
peak in week two. By week two and three, most of the BMSCs had differentiated into 
osteoblasts and were in the mineralization phase. Mineralization of the ECM was 
detected using the calcium content assay. Calcium content in the week two osteogenic 
samples increased significantly from the amount measured in week one. The amount 
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of calcium in the osteogenic group increased progressively over the weeks while the 
control group had negligible calcium deposition. Von Kossa staining of the constructs 
also showed calcium deposition in the osteogenic group while the control samples did 
not show presence of calcium. The gene expression study also corroborated the 
calcium assay as osteopontin was upregulated in the osteogenic group in week two and 
three. Osteopontin is a protein sectred by osteoblasts, binds cell-surface integrin 
receptors, and regulates mineralization[128]. Osteopontin is expressed throughout 
matrix maturation. 
 
Under osteogenic stimulation, proliferation of BMSCs was higher than the 
control. BMSCs also demonstrated its ability to differentiate into the osteoblastic 
lineage and deposited mineralized ECM. BMSCs are a promising source of cells for 
bone tissue engineering. They can be easily isolated from bone marrow aspirates, 
proliferate and differentiate in vitro. Many studies have also proven that it is able to 
differentiate down the osteogenic lineage.     
 
4.3.3.2 PEMF Stimulation on 3D Scaffolds 
 PEMF stimulation did not seem to have an effect on the proliferation of the 
cells. Both exposed and control groups’ DNA content increased gradually over the 
three weeks’ culture, but there were no significant differences between the groups at 
all the weekly time points. This might be due to factors like the state of cell confluence, 
PEMF parameter settings, or the type of substrate surface.  
 
Reported effects of PEMF on cellular proliferation have been contradictory 
[98]. PEMF stimulation did not affect the proliferation of bone marrow fibroblasts at 
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confluent and post-confluent cultures [142]. However, PEMF stimulation significantly 
increased the proliferation of sub-confluent chondroblasts [143], osteoblasts, human 
osteoblast-like cells, MG-63, and TE-85 cell lines [101]. Diniz et al (2002) reported 
that PEMF stimulation increased the osteoblast proliferation until day 7 when the cells 
became confluent and started to form multilayers. After day 7, there was no significant 
difference in DNA content between the PEMF group and the control until the end of 
the experiment [98]. 
 
In this present study, the cells were seeded via direct pipetting onto the surface 
of the scaffold. As a result, most of the cells were attached near the surface and did not 
manage to penetrate deep into the interior. It was likely that by week one, the cells 
have already grown to confluence on the superficial periphery of the scaffold. Hence, 
PEMF stimulation would not serve to enhance the proliferation any further. In addition, 
as the MSCs transited into differentiation stage, cellular proliferation had to be down-
regulated [121]. This could also be the reason for the lack of further PEMF effects on 
cellular proliferation in the post-confluent stages of the culture.   
 
After PEMF exposure for 3 weeks in culture, there were observed differences 
in the normalized ALP activity. ALP activity was significantly higher in the PEMF 
exposed group relative to control at week 1. Apart from that, the general trend was 
similar to earlier studies, with the ALP activity peaking at week one and declining over 
the culture period. Studies done by other groups have demonstrated that ALP activity 
is modified by PEMF stimulation to bone cells [99] and the results in this study 
corroborated this. The normalized calcium deposited in the PEMF exposed group at 
the end of the study was also significantly higher than the control group. Since the 
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number of cells in the exposed and control group at week three are similar, it suggested 
that PEMF stimulation had modulated the osteogenesis of the BMSCs and increased 
the formation of bone-like tissue formation. 
 
There have been a number of studies investigating the effects of PEMF 
stimulation on cell lines in vitro. Earlier studies examined mostly osteoblasts and other 
bone cells like osteoclasts, MC3T3 and SAOS-2, while in more recent publications 
mesenchymal stem cells are increasingly being studied as well. Tsai et al (2009) 
investigated PEMF stimulation on the osteogenesis of MSCs in 2D cultures and found 
that the production of ALP was significantly enhanced on day 7 as compared to 
unexposed controls [118]. This was in agreement with the finding in this study even 
though a 3D culture model was used. In Tsai’s study, he also reported that based on 
alizarin red S staining, the accumulation of calcium deposits reached their highest 
levels at day 28. Alizarin S staining is a qualitative technique whereas in this thesis’ 
study, calcium assay was used to measure the calcium in a quantitative manner. The 
calcium assay results also showed calcium deposition in the PEMF exposed group was 
significantly higher than the control group.  
 
In conclusion, the results demonstrated that MSCs in 3D scaffolds maintained 
in osteogenic medium responded to PEMF stimulation. Enhancement in proliferation 
was not detected in weeks 1, 2 and 3, probably due to the confluent state of the cells by 
week 1. Differentiation of the MSCs into osteoblasts was enhanced as shown by the 
higher ALP activity in the exposed group. At the end of the culture, the PEMF exposed 
samples also had more calcium deposition. These data suggest that extremely low 
frequency and low amplitude PEMF could be used to enhance the osteogenic potential 
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of MSCs and this technology could find promising applications in regenerative 
medicine. 
 
4.4 Concluding remarks 
A silk sponge scaffold was developed in the stage of the project. The scaffold 
provided a suitable 3D environment for the culture of MSCs. The cells attached well to 
the scaffold and displayed good morphology. Under osteogenic stimulation, the cell-
seeded construct was able to differentiate into osteoblasts and form mineralized ECM 
as shown by the high ALP activity and detection of calcium deposits. The silk sponge 
scaffold was subsequently used to study the effects of PEMF stimulation on MSCs 
seeded in a 3D static culture model. The findings showed that PEMF exposure to 
MSCs in a 3D environment enhanced the production of mineralized ECM, as evident 
by the significantly higher calcium deposits. One limitation in this stage was the poor 
seeding technique, which resulted in uneven distribution of cells throughout the 















Stage III: Development of a perfusion bioreactor system 
 
5.1 Materials and methods 
5.1.1 Perfusion chamber design 
The flow perfusion bioreactor was machined from solid polycarbonate. 
Polycarbonate is sterilizable by autoclaving or ethylene oxide gas exposure. It is also 
relatively easy to machine and fabricate into various designs. As illustrated in Figure 
5.1, the individual flow chamber comprises of a top and bottom compartment. The 
bottom compartment has a cylindrical chamber measuring 5 mm diameter by 8 mm 
deep, which enables it to accommodate scaffolds up to 8 mm thick. The diameter of 
the exit port (2 mm) is designed to be smaller than the diameter of the scaffold (5 mm) 
so that the scaffold does not slip through during operation. The top compartment acts 
as a cover to seal the bioreactor chamber. A Viton O-ring is fitted in between the top 
and bottom compartment to prevent leakage of medium. The bioreactor chamber is 
designed to have medium flowing in one direction from the top compartment towards 
the bottom compartment. Four M3 nylon screws are used to tighten the bioreactor 
chamber. The bioreactor chamber is connected to the rest of the perfusion setup using 
pipe fittings from Cole Parmer and PharMed BPT tubing. 
 
The housing of scaffolds in individual chambers offers several advantages. It is 
easier to perform cell seeding and harvesting of samples without affecting the other 
chambers. There is also lesser risk of cross contamination as each chamber is a closed 
system and also does not share culture medium with other chambers. The diameter of 
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the chamber is designed to have a tight tolerance to the dimensions of the scaffold 
being cultured. A tight fit of the scaffold against the chamber walls reduces the 
undesirable and non-perfusing flow around the scaffold.    
 
 
(a)                                                                    (b) 
Figure 5.1: Drawing of the bioreactor chamber. (a) Sectioned view of the top and 
bottom compartment of the bioreactor chamber. The scaffold (grey) is positioned in 
the scaffold housing. The top and bottom compartments are combined and secured 
using four M3 nylon screws. (b) Isometric view of the bioreactor chamber   
   
 
5.1.2 Perfusion bioreactor system setup   
Figure 5.2(A) shows a schematic setup of the perfusion bioreactor system. The 
main features in the perfusion system are namely the perfusion chamber, medium 
reservoir, cell seeding port, media changing port, and a peristaltic pump. Other than 
the peristaltic pump, all the other elements are housed inside the incubator. The 
assembly of the bioreactor is done in a sterile manner inside a laminar flow cabinet. 
Briefly, the scaffold, measuring 5 mm diameter and 5 mm thick is loaded into the 
perfusion chamber and then tightened and connected to the port and medium reservoir 
using tubings, according to the arrangement shown in Figure 5.2(A). The multichannel 
Direction of medium flow 
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pump is capable of running up to 12 perfusion chambers in parallel and after the 
assembly is done, they will be transferred to the incubator. Figures 5.2(B) show the 
assembled bioreactor system with the medium reservoirs and the perfusion chambers 
positioned within the incubator. Tubings are linked to the peristaltic pump located 




Figure 5.2: (A) Schematic of a single perfusion circuit, showing how the various 






5.1.3 Perfusion seeding of cells and medium change 
The perfusion bioreactor system was designed to support dynamic seeding of 
scaffolds. The scaffold was loaded into the perfusion chamber using a pair of sterile 
forceps. Next, the perfusion chamber was sealed and connected to the medium 
reservoir and seeding port. The assembled unit was transferred into the incubator 
where it was linked up to the peristaltic pump outside and allowed to prime for at least 
2 hours to allow culture medium to wet the scaffold and prime the entire perfusion 
circuit. Each medium reservoir contained 20 ml of culture medium and approximately 
5 ml of medium was required to fill up the entire length of tubing and chambers. After 
the circuit was primed, cells were harvested from T175 culture flasks using trypsin 
treatment and counted using a hemocytometer. One million cells were prepared in a 1 
ml cell suspension and a 1 ml syringe was used to draw out this suspension. To seed 
the scaffold, the peristaltic pump was switched off and the syringe was connected to 
the seeding port (Figure 5.3A) where the cell suspension was slowly injected into the 
perfusion circuit. The syringe was removed after seeding and a stopper fitting was 
inserted to close the circuit. The peristaltic pump was then switched on to circulate 
culture medium through the circuit and allow cells to be seeded into the scaffold 
housed within the perfusion chamber. The pump setting for dynamic seeding was set at 
a flow rate of 0.58 ml/min for 3 hours, after which it would be switched off for 12 
hours to allow cell attachment. After 12 hours, the pump was switched on again and 
the flow rate was set to a slower flow rate of 0.11 ml/min for long term culture of the 
cell seeded construct inside the incubator at 37oC, 5% CO2.  
 
Due to the large volume of medium relative to the scaffold, medium change 
was done only once a week. A syringe was used to draw out 10 ml of culture medium 
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from the seeding port (Figure 5.3B) and replaced with an equal volume of fresh 
osteogenic medium using a new syringe. Precautions against contamination were taken 
by wearing sterile gloves, avoiding medium spillage and ensuring that the parts did not 
come into contact with any other surface besides the user’s sterile gloves. 
 
  
(A)      (B) 
 
Figure 5.3: Photographs of the seeding port and the medium changing port 
 
5.1.4 Flow rate characterization  
 The dimensions of the PharMed BPT tubing were inner diameter 1.50mm and 
external diameter 4.76mm. The flow rate of the peristaltic pump was calibrated against 
the digital pump settings using the aforementioned tubing size. The length of the 
tubing used during calibration was the same as the length to be used during actual 
experiments. The peristaltic pump was fully loaded with 12 pump cassettes as per 
actual study. Water was drawn from one end of the tubing which was immersed in a 
beaker of water and collected at the other end into a 15ml tube. The average volume of 
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water collected within a specified time period was measured and the flow rate 
calculated. 
   
5.1.5 Cell seeding efficiency 
Three hours after the scaffolds were seeded with cells, the bioreactor chamber 
was disconnected and the medium in the tubing was collected into the medium 
reservoir. The medium reservoir was centrifuged at 1500rpm for 5 minutes to collect 
the cells that did not attach onto the scaffold during perfusion seeding. The seeding 
efficiency was calculated by finding the percentage of the number of cells attached 
onto the scaffold over the number of cells seeded per scaffold.  
 
5.1.6 Cell seeding distribution 
Live cell staining was also done 24 hours after seeding to observe the viability 
and distribution of the seeded cells on the scaffold. The sample was washed with PBS 
and cut into 4 sections along the sagittal plane, as illustrated in Figure 5.4. The sections 
were incubated in 1 ml of medium containing 5 mg/ml fluorescein diacetate (FDA) 
dye for 3 minutes at room temperature. The stained sections were then rinsed with PBS 
and 1 ml of PBS was added to keep the sections wet. The sections were examined 
using an inverted fluorescence microscope (IX71 Inverted Research Microscope, 





(a)                                                (b) 
Figure 5.4: Schematic showing how the scaffold was sectioned in the sagittal direction. 
(a) The scaffold represented by the yellow cylinder was cut into 4 sections. The two in 
the central region were labeled as MID while the two at the sides were labeled SIDE. 
(b) An example of how a section looks like. The green spots represent the cells when 
stained with FDA fluorescent dye  
 
5.1.7 Pico green assay 
Samples (n = 3) from each group were collected at weekly time points to assess 
cell proliferation. The cell-seeded scaffolds were rinsed with ice-cold water to remove 
traces of culture medium, transferred into cryovials and stored in a liquid nitrogen tank. 
Analysis of samples was performed together after samples from all time points were 
harvested, so as to ensure consistency. Prior to analysis using PicoGreen, the samples 
were freeze dried to ensure no water in the samples. Different water content would 
interfere with the DNA concentration and hence the PicoGreen results.  
 
The measurement of the cell number in each well was assessed using the 
Quant-iT PicoGreen dsDNA reagent kit (Invitrogen), which is an ultrasensitive 
fluorescent nucleic acid stain for quantitating double-stranded DNA in solution. The 
freeze dried samples were broken up into powder using a pipette tip and treated with 
Buffer RLT Qiagen) cell lysis buffer. The cell lysate was homogenized via repeated 
pipetting. A fresh tip was used for each sample and care was taken to try and minimize 
the loss of homogenate. The tubes were vortexed for 5 minutes and then centrifuged at 
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16,000 rpm for 5 minutes. 20 µL of cell lysate was mixed with 80 µL of PicoGreen 
dye, prepared based on the manufacturer’s protocol, in 96-well black plates. 
Fluorescence intensity was measured using a FLUOstar Optima fluorescent plate 
reader (BMG Labtech, Offenburg, Germany) at 520 nm wavelength after excitation at 
485 nm, using a gain of 1000, 10 flashes per well and a position delay time of 0.2 to 
0.5s. The relative fluorescence unit value read using the machine was compared 
against a DNA standard curve to obtain the DNA content in each sample. 
 
5.1.8 ALP assay 
To assess the osteogenic differentiation of the cells, ALP activity of the 
samples (n = 3) were measured using the Phosphatase Substrate Kit (PIERCE). 
Samples were first washed with PBS, and then incubated with 1000 µL solution of 
para-nitrophenyl phosphate (pnPP) disodium salt in Diethanolamine Substrate Buffer 
(1mg/ml) for 1 hour in a humidified atmosphere of 5% CO2 at 370C. After 1 hour, 500 
µL of 2N sodium hydroxide was added to stop the reaction. The absorbance values 
were measured at 405 nm immediately using a microplate reader. The ALP activity 
was calculated using the formula given by the manufacturer.  
 
5.1.9 Calcium content assay 
To measure the amount of calcium deposited during osteogenesis, a 
colorimetric assay based on the calcium O-cresolphthalein complexone methodology 
was carried out using the Calcium (CPC) LiquiColor tes (Stanbio Laboratory, TX). 
Samples (n = 3 per group) were first washed with PBS and then incubated with 500 µL 
of 5% trichloroacetic acid (TCA) at room temperature for 30 minutes. The samples 
were transferred to a micro-centrifuge tube and centrifuged at 16,000 rpm for 5 
132 
 
minutes to sediment the cell debris. 30 µL of each sample was added to 300 µL of the 
working reagent. Aliquots of 100 µL were pipetted in triplicates into 96-well plates. 
Absorbance values were measured at 575nm using a microplate reader. A standard 
curve was done using the calcium standards provided by the manufacturer and the 
absorbance readings of the samples were read off the standard cure to obtain the 
concentration of calcium in each sample.     
 
5.1.10 Statistical analysis 
All data were presented as mean ± standard deviation. Multiple comparisons 
were performed using one-way ANOVA and posthoc Tukey tests. Pairwise 
comparisons were performed using two-tailed Student t-tests (SPSS 13.0 software 
package). p<0.05 was accepted as statistically significant. 
 
5.2 Results 
5.2.1 Characterization of pump flow rate 
 
Figure 5.5: Calibration line for adjusting desired medium flow rate 
y = 1.0506x 

















Pump speed (RPM) 
Pump flow rate chart 
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The calibration chart of the multichannel peristaltic pump is as shown in Figure 
5.5. This chart will enable the user to set the rotation speed of the rotor according to 
the desired medium flow rate. 
 
5.2.2 Seeding efficiency 
 The seeding efficiency of the perfusion seeding method was 91.50 ± 1.55% 
compared to 89.04 ± 2.86%. There was a slight improvement in seeding efficiency 
though it was not statistically significant. 
 
Figure 5.6: Seeding efficiencies of static versus perfusion seeding 
 
5.2.3 Seeding distribution 
Figure 5.7 shows the cell distribution of cells in the cross section of the 
scaffold, taken 24 hours after cell seeding. Figure 5.7A shows the mid section of a 
scaffold which was seeded using perfusion seeding technique. Figure 5.7B shows the 
mid section of a scaffold which was seeded using static seeding technique. Constructs 
which were seeding using the perfusion bioreactor displayed a more even cell 
distribution. The images clearly show cells which have penetrated into the interior of 
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the scaffold. On the other hand, statically seeded constructs had highly uneven cell 
distribution. The intense green fluorescence at the top region represents a high 
concentration of cells attached. Only a little fluorescence signal was picked up at the 
scaffold interior. 72 hours post seeding, the cell distribution in the perfusion seeded 
construct still displayed a homogeneous cell distribution across the scaffold, indicating 


















Figure 5.7: FDA staining showing the distribution of cells 24 hours after seeding. (A) 
Mid section of scaffold seeded using perfusion bioreactor. (B) Mid section of scaffold 









Figure 5.8:  FDA staining showing the distribution of cells 72 hours after seeding. (A) 
Mid section of scaffold seeded using perfusion bioreactor. (B) Mid section of scaffold 





5.2.4 DNA content 
 The DNA contents of the samples from bioreactor and static culture are as 
shown in Figure 5.9. The amount of DNA content in each group was approximately 
constant throughout the period of culture. Constructs cultured in the perfusion 
bioreactor had significantly lower DNA compared to those cultured in static well 
plates.   
 
Figure 5.9: Pico green assay measuring DNA content of silk sponge scaffolds cultured 
in the perfusion bioreactor chamber and in static well plates (#p < 0.05) 
 
5.2.5 ALP activity 
 The normalized ALP activities of the MSCs in bioreactor and static culture are 
as shown in Figure 5.10. The normalized ALP activity followed a characteristic rise 
and fall in activity, reaching a peak in week two for both groups. ALP activity in the 
BIOR group was not significantly higher than the STATIC group except for week two. 
There was a significant rise in ALP activity in BIOR group from week 1 to 2 and a 




Figure 5.10: Normalized ALP activity of silk sponge scaffolds cultured in the 
perfusion bioreactor chamber and in static well plates (#p < 0.05) 
 
5.2.6 Calcium content 
 The normalized calcium deposition of constructs cultured in bioreactor and 
static cultures are shown in Figure 5.11 below. 
 
Figure 5.11: Normalized calcium deposition of silk sponge scaffolds cultured in the 




Calcium was detected as early as week one of culture. Constructs cultured in the 
perfusion bioreactor deposited significantly greater amounts of calcium compared to 
those cultured in static culture. For both group, calcium content rose significantly from 




Bioreactors play an important role in tissue engineering as they mimic in vivo 
conditions in an in vitro setting for growing tissue engineered constructs. They also 
allow investigators to study the responses of cells to mechanical and biochemical cues 
in a systematic and controlled manner. For bone tissue engineering, bioreactors 
overcome the limitations of mass transfer of nutrients and wastes, making it possible to 
culture larger tissue constructs in vitro.  
 
Several types of bioreactors are available for bone tissue engineering 
applications, namely the spinner flask, rotating wall vessel and the flow perfusion 
bioreactors. All the three types of bioreactors have shown good results for tissue 
engineering purposes [60, 65, 66, 144, 145]. Spinner flasks are low cost setups, but the 
non-uniform media flow around scaffolds hamper their use. At the exterior surface of 
scaffolds, cells are exposed to turbulent flow whereas cells in the interior experience 
static molecular diffusion [59]. Rotating wall vessel also faces similar problems. 
Sikavitsas et al (2001) showed that while RWV and spinner flasks have positive 
effects on the proliferation and differentiation of marrow stromal osteoblasts seeded on 
PLGA porous scaffolds, cell growth and mineralization for all culturing conditions 
were limited to the outside of the scaffolds. Internal nutrient transport limitations were 
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not eliminated [144]. In this study, the flow perfusion was being used to culture tissue 
engineered constructs from silk sponge scaffolds and MSCs. A flow perfusion system 
overcomes these issues because medium is flushed directly through scaffolds [66, 145], 
hence providing nutrient and stimuli throughout the entire volume of the scaffold [59].  
 
The seeding efficiency of this perfusion system was 91.5% compared to 89.0% 
achieved in static seeding technique. Although there was only a slight improvement in 
efficiency, the advantage of dynamic seeding using the perfusion chamber was clearly 
seen in the seeded cell distribution. From the FDA staining of the sagittal cross 
sections, it was observed that perfusion seeding resulted in better penetration of cells 
into the scaffold interior and cell distribution was more homogeneous across the cross 
section. Cells in statically seeded scaffolds were concentrated mostly near the 
periphery of the scaffold and were not able to penetrate deeply. An effective bioreactor 
system has to induce a cell distribution that is as homogeneous as possible so as to 
generate a uniformly distributed ECM [146]. A better ECM will result in a more 
functional tissue engineered construct.  
 
In setting the parameters for the perfusion bioreactor, it was important to select 
flow rates that mimicked the physiological conditions. It has been reported that 
mechanical stimulation via flow perfusion enhanced the osteogenic differentiation of 
cell seeded constructs [55, 56, 147-149]. Among the studies which reported success in 
using perfusion bioreactors, it was noted that volumetric flow rate was the independent 
variable which was usually mentioned [64, 65, 147, 150, 151]. However, the problem 
is that the same flow rate passing through two scaffolds with different porosity, pore 
anisotropy and pore sizes could impart greatly different shear stresses on the cells 
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within the scaffold [152]. It is believed that the bone cells are stimulated by the fluid 
shear stresses acting on the cell membranes [153]. According to modeling studies, the 
physiological shear stress acting on the cell membrane is estimated to be 0.06 to 30 
dyne/cm2 depending on the loading mechanism like normal extravascular pressure, 
locomotion or posture maintenance [153-155]. Studies using the perfusion type 
bioreactor have used volumetric flow rates between 0.01 and 3.0 ml/min [55, 147, 148, 
156]. This translated to estimated shear stresses ranging from 0.1 to 6.0 dyne/cm2. In 
this study, the seeding flow rate was 0.58 ml/min and the maintenance flow rate for 
long term culture used in this study was 0.11 ml/min. These flow rate values were 
closer to the lower limit generally used by other investigators. In terms of estimated 
shear stress, it is likely to within the physiological range of shear stresses.  
 
From the above, it is obvious that one of the challenges faced in this perfusion 
bioreactor system is in quantifying the shear stresses. The factors influencing local 
shear stresses are media flow rate and dynamic viscosity, bioreactor configuration, and 
porous scaffold micro-architecture [152]. The general pore architecture of the silk 
scaffold is considered to be random even though steps were taken during fabrication to 
ensure that the pores were of a homogenous shape and size. Calculating flow mediated 
shear stress within a complex 3D porous structure is not trivial [152], requiring 3D 
computational fluid models which is beyond the scope of this project. However, such 
models are useful as it could allow comparison of data from different perfusion 
bioreactor systems or scaffold micro-architecture. In doing so, specific shear stress 




As a proof of efficacy, the perfusion bioreactor system was used to culture 
MSCs seeded onto silk sponge scaffolds for three weeks. The proliferation, 
differentiation and ability to form mineralized ECM were monitored on a weekly basis. 
In both bioreactor and static culture models, cells maintained their numbers over the 
entire period. The DNA content of cells measured in the bioreactor culture was lower 
than the static culture at all time points. This could be due to a ‘washout’ effect as cells 
attached on the face which was directly exposed to the oncoming flow tend to be 
removed due to fluidic forces [157]. When the forces generated by fluid flow surpass 
the adhesive forces generated through integrin-matrix interaction, cells would get 
physically detached from the scaffold [158]. 
 
ALP is an early marker of early osteoblastic differentiation. The ALP activities 
were measured at week 1, 2 and 3 of the study and normalized with the DNA 
concentration. The characteristic rise and fall of ALP activity was observed (Figure 
5.10) in both static and bioreactor cultures. In the perfusion culture, ALP activity was 
significantly higher in week 2 and 3 compared to the statically cultured samples. This 
indicated that the flow perfusion of medium through the scaffold had an influence on 
the osteogenic differentiation of MSCs in vitro. It is believed that the mechanical 
stimulation imparted by the flowing medium encouraged the cells to differentiate into 
osteoblasts. As the study progressed, the cells began to deposit mineralized ECM onto 
the scaffold. This was measured using the calcium content assay and it was observed 
that the calcium content increased over time and was significantly higher in the 




These findings were in agreement with works of other investigators. Mueller et 
al (1999) showed that culturing murine K8 osteosarcoma cells in collagen sponges in 
flow perfusion bioreactors led to enhanced ALP activity and mineralization relative to 
static culture [64]. Similarly, Bancroft et al (2002) studied marrow stromal osteoblasts 
seeded onto titanium fiber meshes and reported great increases in calcified matrix 
production and total calcium content relative to static controls [147]. In more recent 
works, Li et al (2009) cultured human BMSCs on β-tricalcium phosphate scaffolds 
using a perfusion bioreactor. He reported that increasing the flow shear stress 
accelerated the osteogenic differentiation of human MSCs and improved the 
mineralization of ECM [159].  
 
Overall, it has been demonstrated that the perfusion bioreactor system designed 
in this study was capable of maintaining cell viability, enhancing ostegenic 
differentiation and mineralized ECM formation of MSCs cultured in osteogenic 
medium. 
 
5.4 Concluding remarks 
In stage III of the project, a perfusion bioreactor system was designed and built. 
The investigator demonstrated the efficacy of the bioreactor in performing dynamic 
cell seeding. Constructs that were seeded using the system showed superior cell 
distribution over the statically seeded control. The perfusion bioreactor system also 
proved that it was able to maintain the viability of cell-seeded constructs over a three 
weeks study. Constructs cultured in the bioreactors showed enhanced osteogenic 
differentiation and mineralized matrix formation over a static culture model. This 





Stage IV: Integration of PEMF unit with flow perfusion bioreactor 
 
6.1 Materials and methods 
6.1.1 Integrated setup of PEMF stimulation with perfusion bioreactor system 
To study the effects of PEMF stimulation on a cell-seeded construct in a 
dynamic environment, the perfusion bioreactor chambers were positioned inside the 
solenoids. An acrylic holder capable of holding two perfusion chambers was fabricated 
to immobilize them in a horizontal configuration within the solenoids (Figure 6.1). 
Two holders were used for each solenoid to support 4 perfusion chambers within the 
region of uniform electromagnetic field. The assembled setup is as shown in Figure 6.2. 
Three solenoids from the PEMF-exposed group were placed side by side on the lower 
rack. The control group which was not subjected to PEMF exposure was placed on the 
upper rack. A magnetic field sensor was used to detect any traces of EMF on the upper 
rack and a magnetic field of 0.070 mT was measured. To shield the control group 
samples from the PEMF, two layers of the steel shelving were added to separate the 
study and control group. The background EMF dropped to 0.020 mT after the 





Figure 6.1: Schematic cross section of the solenoid, showing the acrylic holder (in gray) 
supporting two perfusion chambers. 
 
 
Figure 6.2: Photo of the incubator setup, PEMF exposed group was placed at the lower 







6.1.2 In vitro culture of cell seeded construct within integrated setup 
A 3-week study was designed to study the synergistic effect of PEMF and 
perfusion stimulation. The study was divided into the PEMF exposed and sham 
exposed group, which were run concurrently in the same incubator. Each group had 6 
cell-seeded scaffolds in their respective perfusion chambers, to be assigned for various 
assays to assess the proliferation, differentiation, calcium deposition and gene 
expression. Due to the limited number of samples, each scaffold had to be cut into half 
using a sterile scalpel blade for the various assays. As the peristaltic pump could only 
support 12 perfusion chambers at a time, the experiment had to be conducted in 
batches. After one week of culture, all the samples were harvested for testing and the 
equipment was washed and re-sterilized for setting up to run a two week culture. This 
cycle was repeated for the three weeks’ culture.  
 
Both groups used silk sponge scaffolds (5mm diameter and 5mm thick), each 
seeded with 106 MSCs from the 3rd passage. Perfusion seeding was used and the 
seeding flow rate was 0.58 ml/min. Both groups were cultured in osteogenic medium 
which was flowing at a maintenance flow rate of 0.11 ml/min. The PEMF exposed 
group was exposed to 8 hours of continuous stimulation followed by 16 hours of rest 
each day for 3 weeks. The applied field consisted of rectangular pulses repeating at a 
frequency of 7.5Hz and a magnetic field strength of 1.8mT. Medium change was done 
once a week. Before and after each medium change, the PEMF parameters were 
checked using the magnetic sensor. Unnecessary opening and closing of the incubator 





6.1.3 Pico green assay 
Samples (n = 3) from each group were collected at weekly time points to assess 
cell proliferation. The perfusion chamber was removed from the incubator and the 
construct was harvested in the laminar flow cabinet. The cell-seeded scaffolds were 
rinsed with ice-cold water to remove traces of culture medium, transferred into 
cryovials and stored in a liquid nitrogen tank. Analysis of samples was performed 
together after samples from all time points were harvested, so as to ensure consistency. 
Prior to analysis using PicoGreen, the samples were freeze dried to ensure no water in 
the samples. Different water content would interfere with the DNA concentration and 
hence the PicoGreen results.  
 
The measurement of the cell number in each well was assessed using the 
Quant-iT PicoGreen dsDNA reagent kit (Invitrogen), which is an ultrasensitive 
fluorescent nucleic acid stain for quantitating double-stranded DNA in solution. The 
freeze dried samples were broken up into powder using a pipette tip and treated with 
Buffer RLT Qiagen) cell lysis buffer. The cell lysate was homogenized via repeated 
pipetting. A fresh tip was used for each sample and care was taken to try and minimize 
the loss of homogenate. The tubes were vortexed for 5 minutes and then centrifuged at 
16,000 rpm for 5 minutes. 20 µL of cell lysate was mixed with 80 µL of PicoGreen 
dye, prepared based on the manufacturer’s protocol, in 96-well black plates. 
Fluorescence intensity was measured using a FLUOstar Optima fluorescent plate 
reader (BMG Labtech, Offenburg, Germany) at 520 nm wavelength after excitation at 
485 nm, using a gain of 1000, 10 flashes per well and a position delay time of 0.2 to 
0.5s. The relative fluorescence unit value read using the machine was compared 
against a DNA standard curve to obtain the DNA content in each sample. 
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6.1.4 ALP assay 
To assess the osteogenic differentiation of the cells, ALP activity of the 
samples (n = 3) were measured using the Phosphatase Substrate Kit (PIERCE). 
Samples were first washed with PBS, and then incubated with 1000 µL solution of 
para-nitrophenyl phosphate (pnPP) disodium salt in Diethanolamine Substrate Buffer 
(1mg/ml) for 1 hour in a humidified atmosphere of 5% CO2 at 370C. After 1 hour, 500 
µL of 2N sodium hydroxide was added to stop the reaction. The absorbance values 
were measured at 405 nm immediately using a microplate reader. The ALP activity 
was calculated using the formula given by the manufacturer.  
 
6.1.5 Calcium content assay 
To measure the amount of calcium deposited during osteogenesis, a 
colorimetric assay based on the calcium O-cresolphthalein complexone methodology 
was carried out using the Calcium (CPC) LiquiColor tes (Stanbio Laboratory, TX). 
Samples (n = 3 per group) were first washed with PBS and then incubated with 500 µL 
of 5% trichloroacetic acid (TCA) at room temperature for 30 minutes. The samples 
were transferred to a micro-centrifuge tube and centrifuged at 16,000 rpm for 5 
minutes to sediment the cell debris. 30 µL of each sample was added to 300 µL of the 
working reagent. Aliquots of 100 µL were pipetted in triplicates into 96-well plates. 
Absorbance values were measured at 575nm using a microplate reader. A standard 
curve was done using the calcium standards provided by the manufacturer and the 
absorbance readings of the samples were read off the standard cure to obtain the 





6.1.6 Statistical analysis 
All data were presented as mean ± standard deviation. Multiple comparisons 
were performed using one-way ANOVA and posthoc Tukey tests. Pairwise 
comparisons were performed using two-tailed Student t-tests (SPSS 13.0 software 
package). p<0.05 was accepted as statistically significant. 
 
6.2 Results 
6.2.1 DNA content 
The proliferation of cells over the three week period is shown in Figure 6.3 
below. Increase in cell population was not observed as the number of cells in both 
groups was maintained at a range of 3.4 to 4.0µg/ml. The cell number in the PEMF 
group was slightly higher than the control at all time points, but the difference was not 
significant.  
 
Figure 6.3: Pico green assay measuring DNA content of silk sponge scaffolds cultured 
in the perfusion bioreactor chambers. EMF BIOR refers to perfusion chambers 
exposed to PEMF stimulation while SHAM BIOR refers to perfusion chambers 




6.2.2 ALP activity 
The ALP activity of the cells over the three week period is shown in Figure 6.4. 
The ALP activity of both groups displayed the characteristic rise and fall over time as 
the cells undergo differentiation into osteoblasts. ALP activities in the PEMF exposed 
chambers were not significantly higher than the non-exposed chambers, except for 
week 3 time point. 
 
Figure 6.4: ALP activity of the silk sponge scaffolds cultured in the perfusion 
bioreactor chambers. EMF BIOR refers to perfusion chambers exposed to PEMF 
stimulation while SHAM BIOR refers to perfusion chambers without PEMF 
stimulation (#p < 0.05) 
 
6.2.3 Calcium content 
The calcium deposition by the cell-seeded constructs over three weeks is 
shown in Figure 6.5. Significant levels of calcium deposition were detected in the 
PEMF exposed group at the week 1 time point, more than twice of what was deposited 
in the perfusion chambers without PEMF stimulation (0.0496µg/µl versus 0.0199µg/µl 
per unit DNA). The calcium deposition increased significantly from week 1 to week 2 
for both groups, and there was no further increase from week 2 to 3. By the end of the 
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study, samples from both PEMF exposed and non-exposed groups had about the same 
level of calcium deposition (0.0607µg/µ to 0.0632µg/µ per unit DNA). The findings 
indicated that, all else being equal, the exposure to PEMF stimulation led to 
acceleration in calcium deposition for cell-seeded constructs. 
 
Figure 6.5: Calcium content assay measuring the calcium deposition of silk sponge 
scaffolds cultured in the perfusion bioreactor chambers. EMF BIOR refers to perfusion 
chambers exposed to PEMF stimulation while SHAM BIOR refers to perfusion 
chambers without PEMF stimulation (#p < 0.05) 
  
6.3 Discussion 
 The DNA content of the scaffolds in both groups showed a slight increase over 
the study duration. This suggests that cell viability was maintained inside the 
bioreactor chamber and cell proliferation was minimal after week 1. PEMF treatment 
did not significantly enhance cell proliferation over the unexposed control samples. 
The low rate of cell proliferation was probably due to the cells undergoing the 
differentiation phase to become osteoblasts. There is an inverse relationship between 
proliferation and differentiation of normal diploid osteoblastic cells, as shown in 
Figure 6.6 [121]. This effect could be magnified by the fact that both groups were 
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maintained in a perfusion culture from day one of the study. The mechanical 
stimulation provided by the flow mediated shear stress could have promoted the 
differentiation of MSCs in the early stages, leaving little time for the cells to 
proliferate. Another reason for the absence of active proliferation could due to the 
early deposition of ECM by the cells at week one. In Lian and Stein (1992), the 
authors mentioned a model of contributions of the ECM to the regulation of osteoblast 
differentiation, as shown in Figure 6.7 [121]. In this model, the formation and 
maturation of the ECM contributes to down-regulated proliferation. Together, the 
above reasons help to explain the maintenance of cell viability and lack of proliferative 
growth in cell numbers. 
 
 






Figure 6.7: Proposed model of contributions of the ECM and other signaling 
mechanisms that regulate osteoblast differentiation [121] 
  
For both exposed and control groups, the ALP activity of the cells increased 
from week 1 to 2, reached a peak at week 2 and subsequently dropped in week 3. The 
ALP in the PEMF group was significantly higher than the control in week 3. By week 
3 of the study, scaffolds in both exposed and control group had approximately the 
same amount of calcium content. The use of PEMF treatment did not result in greater 
amount of calcium deposition compared to the control. However, the cells in the 
PEMF exposed group had already begun producing significant amount of calcium at 
week 1. In earlier studies of this thesis, significant amounts of calcium were only 
detected at week two of the culture period. These findings suggest that the combination 
of PEMF treatment and flow perfusion environment did not produce a synergistic 
effect on the output of mineralized ECM. However, the combination did seem to 
accelerate the osteogenesis process by bringing forward the deposition of mineralized 
ECM. 
 
In a study by Diniz et al (2002) using osteoblasts (MC3T3-E1 cell line) on 2D 
well plates, he showed that effects of PEMF stimulation on bone tissue like formation 
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are dependent on the maturation stages of the osteoblasts [98]. PEMF treatment of the 
osteoblasts in the active proliferation (P) stage accelerated cellular proliferation, 
enhanced cellular differentiation and increased bone tissue-like formation. PEMF 
treatment of osteoblasts in the differentiation (D) stage enhanced cellular 
differentiation and increased bone tissue-like formation. PEMF treatment of 
osteoblasts in the mineralization (M) stage decreased bone tissue-like formation. In 
this current study, the investigator has chosen to expose the samples to PEMF 
stimulation for the entire duration of the study, that is, the P, D and M stage. From the 
results, it seemed that exposure to PEMF at the middle and late phases of the culture 
did not appear to enhance the osteogenic outcomes. On the other hand, early exposure 
to PEMF in the first week of culture led to greater calcium deposition relative to 
control. This suggests that PEMF stimulation on MSCs might follow similar patterns 
and limiting PEMF exposure to the early stages could yield greater benefits. 
 
Till date, there is no work done on studying the responses of MSCs to PEMF 
stimulation using a 3D culture model, much less using any bioreactor systems. The 
only similar work done was a pilot study by Tsai et al (2007) using rat osteoblasts, 
PLGA scaffolds, PEMF apparatus and a type of gas-induced bioreactor [102]. 
Furthermore, the actual mechanism to how PEMF affects cellular responses in 
osteogenesis is still not clear yet. 
 
There have been studies which attempted to shed light on the signaling 
pathways which happens during stimulation. Brighton et al (2001) studied the 
biochemical pathways that are activated in signal transduction when various types of 
electrical stimulation are applied to bone cells (MC3T3-E1 osteoblasts) [119]. His 
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approach was to expose cultures of osteoblasts to capacitive coupling, inductive 
coupling, or combined electromagnetic fields for thirty minutes, two, six and twenty 
four hours to study dose response. He also exposed groups of osteoblasts to two hours 
of stimulation in the presence of various chemical inhibitors of signal transduction. 
Twenty four hours after the start of stimulation, the DNA content was determined. The 
result was that all three signals produced a marked increase in DNA content compared 
to the controls at all time points. The signaling pathways elucidated from the 
experiments were summarized into the schematic shown in Figure 6.8.  
 
Brighton concluded that the initial events in signal transduction were different 
for the three forms of stimulation. However, the final pathway is the same for all three 
signals. There is an increase in cytosolic Ca2+ and an increase in activated calmodulin 
[119]. As the time frame for Brighton’s study was restricted to 24 hours and he 
specifically looked at cell proliferation, it was difficult to extrapolate for longer time 
frames (more than 7 days) or explain any direct effects of PEMF on the 
differentiation/mineralization pathways. Nevertheless, the results are in agreement 
with the findings of other studies that PEMF accelerates cell proliferation at the early 





Figure 6.8: Schematic drawing of the signaling pathways followed by the three forms 
of electrical stimulation. The pathway followed by mechanical strain (cyclic, biaxial, 
0.17% strain) is also included [119] 
  
Another interesting observation made from the above model is that mechanical 
and PEMF stimulation converge into the same common pathway, resulting in an 
increase in cytosolic Ca2+ and an increase in activated cytoskeletal calmodulin. This is 
relevant to the thesis’ study of combined stimulations. Sharing a common downstream 
pathway implies that there is an upper limit to the amount of activated calmodulin 
which will lead to increased cell proliferation. In this study, the application of PEMF 
did not enhance the cell proliferation of samples cultured in the perfusion bioreactor 
system. It might be because the mechanical stimulation introduced by the medium 
flow has already stimulated the cells to proliferate more and further stimulation using 





6.4 Concluding remarks 
In this stage 4 of the project, scaffolds seeded with MSCs were cultured with 
osteogenic medium in a perfusion bioreactor system and exposed to PEMF stimulation. 
The aim was to prove the hypothesis that combined mechanical and PEMF stimulation 
would result in synergistic production of mineralized ECM. The results showed that by 
the end of the study, combined stimulation did not lead to synergistic production of 
mineralized ECM compared to the control group. However, the results showed that 
combined stimulation allowed significant calcium deposition to occur earlier. This has 
potential implications in using PEMF technology with bioreactors to accelerate the 
development of functional bone graft substitutes.  
 
To conclude, the response of cells to PEMF stimulation in vitro depends on 
several factors like the PEMF exposure parameters (frequency, intensity, and exposure 
duration), stages of cell development, types of cells, confluence of cell culture, 2D/3D 
environment, types of substrates and topography. As the study of PEMF on MSCs is 
still relatively new, more studies are required to gain a deeper understanding into this 













Summary of Findings and Conclusion  
 
7.1 Introduction 
 Bone graft, being the second most commonly implanted tissue are in high 
demand for a wide range of orthopaedic clinical problems. Current gold standard in 
bone graft is fresh autogenous bone. Allograft and synthetic grafts are alternative, each 
with their own pros and drawbacks. Bone tissue engineering is seen as a potential 
means of addressing the short supply of bone grafts. To obtain clinically relevant 
volumes of bone graft, suitable scaffold materials, cell source and bioreactor systems 
were developed. Apart from these, biophysical stimulation like electromagnetic field 
stimulation has been known to promote bone growth and treat non-bony unions in 
fractures. Applying this technology together with bioreactor systems represents a 
potential way of developing more effective bone grafts.   
 
7.2 Objectives and Hypotheses 
The objective of this project was to study the response of BMSCs to combined 
mechanical and PEMF stimulation, with the aim of developing means to enhance the 
formation of bone in tissue engineering applications. 
The hypotheses of this project were: 
(3) MSCs exposed to PEMF stimulation will result in improved ECM mineralization 
(4) The combined stimulation of fluid flow and PEMF stimulation on MSCs seeded in 




The specific aims of this project were: 
(5) Demonstrate proof of concept that PEMF stimulation affects the osteogenic 
development of MSCs. 
(6) Develop a suitable silk based sponge scaffold for the seeding and culture of MSCs. 
(7) Develop a perfusion bioreactor system and demonstrate its proof of efficacy in 
culturing tissue engineered bone constructs. 
(8) Investigate the effects of combining PEMF stimulation and mechanical stimulation 
via fluid flow on the production of mineralized ECM in MSCs seeded on silk 
scaffolds. 
 
7.3 Summary of findings 
7.3.1 Proof that PEMF stimulation affects the osteogenic development of MSCs 
Stage 1 of this study involved characterizing rabbit MSCs as the cellular source 
and designing the PEMF stimulation apparatus. The in vitro experiments demonstrated 
that rabbit MSCs were able to differentiate into osteogenic lineage. The PEMF 
stimulation unit was assembled using function generators, current amplifier circuit and 
solenoids made from copper wires wound onto an acrylic cylinder. The MSCs were 
maintained inside the solenoid and subjected to PEMF treatment throughout the 
duration of culture. The aim was to use a 2D culture model to investigate how MSCs 
in osteogenic medium respond to PEMF treatment.  
 
Prior to the start of this project, earlier studies of PEMF stimulation were 
mostly on bone cells such as osteoblasts, osteoclasts and osteosarcoma cell lines. There 
were no studies investigating the effects of PEMF treatment on MSCs. Shortly after 
stage 1 of this study began, a few studies on PEMF and MSCs appeared in publications 
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[116-118]. Using human MSCs, these investigators reported that PEMF exposure 
accelerates cell proliferation, enhances differentiation and results in more extensive 
staining calcium. The findings in this thesis’ study are in agreement with these works 
to a large extent. Results of this study demonstrated greater amount of collagen 
production and calcium content in the PEMF exposed group relative to control.  
 
Therefore, it was shown that PEMF does exert a positive effect on MSCs which 
are directed towards the osteogenic lineage. This has enabled the investigator to 
proceed with the rest of the stages, which aimed at studying how the MSCs respond to 
PEMF treatment in a 3D environment and how does it differs from a 2D setting.  
 
7.3.2 Silk sponge scaffold for seeding and culturing MSCs 
 Stage 2 of the study was about designing and fabricating a suitable scaffold for 
culturing MSCs and then exposing the cell-seeded construct to PEMF treatment. This 
study was quite new as current works of PEMF on MSCs are still using 2D culture 
models. Bone cells and MSCs in vivo are subjected to a 3D environment; a 2D culture 
model will not be able to fully explain the effects of PEMF treatment. 
 
A few materials were shortlisted, namely silk, chitosan and hydroxyapatite. 
The investigator explored blending these materials together to combine the advantages 
of these individual materials. Hydroxyapatite was known to enhance the ostegenic 
process of cells. However, as this study was about looking at PEMF effects on 
osteogenesis, the properties of some of these materials might confound the final results. 
Eventually, silk from the B. mori silkworm was chosen as the biomaterial because of 
its attractive properties for in vitro applications. It has a proven record as a suitable 
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scaffold for supporting bone growth, yet at the same time, it does not exert undue 
influence on the osteogenic process.   
 
Raw silk fibers were degummed by boiling in a solution of 0.25% Na2CO3 and 
0.25% SDS to remove the sericin protein. After that the silk fibers were dissolved in a 
ternary solvent, dialyzed and poured into molds to be freeze dried into porous sponges. 
A dermal punch was used to cut the silk scaffold into its final cylindrical shape, 
measuring 5mm diameter and 5mm thickness. The silk sponge scaffold was put 
through several characterization tests and MSCs were statically seeded onto the 
scaffold for in vitro experiments.  
 
The results showed that silk sponge scaffold was able to support MSCs growth 
and differentiation into osteoblasts. When the cell-seeded constructs were exposed to 
PEMF stimulation, it resulted in greater production of calcium compared to the control 
group. One limitation observed was related to the seeded cell distribution and 
penetration. Fluorescent live staining of the scaffold showed that static seeding of cells 
onto the silk sponge scaffold resulted in cells mostly attached to the periphery of the 
scaffold, with very few cells at the interior. The inhomogeneous cell distribution would 
result in uneven deposition of ECM throughout the scaffold, which was not a positive 
result. Hence, there was a need for a better seeding technique and in vitro culture 
system.  
 
7.3.3 Flow perfusion bioreactor as the in vitro culture system 
 In stage 3 of the study, a flow perfusion bioreactor system was designed and 
fabricated by the investigator to culture the cell-seeded constructs. The system 
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consisted of a perfusion chamber to house the silk sponge scaffold, medium reservoir, 
multichannel peristaltic pump, seeding and medium changing port. The concept was to 
have a system which could allow dynamic seeding and long term culture to be done 
together. The perfusion chamber also had to be compact enough for subsequent stage 4 
study where it had to fit into the restricted space within the solenoid.  
 
 The bioreactor system was used to perform dynamic cell seeding of scaffolds 
and the results were quite positive. Compared to statically seeded constructs, the cell 
distribution in the dynamically seeded construct was more even. There was better 
penetration of cells into the scaffold interior as the medium carrying the cell 
suspension perfused throughout the scaffold. The bioreactor system also demonstrated 
its efficacy in supporting the development of cell-seeded constructs over an extended 
period of three weeks. Cell viability was maintained and there was greater deposition 
of calcium in the constructs kept inside the perfusion bioreactors compared to static 
culture constructs. 
 
 The findings highlighted the importance of bioreactor systems for in vitro 
culture. To grow a graft which is large enough to mend critical sized defects, scaffolds 
need to be of a clinically relevant volume and a large number of cells are needed. Yet 
in static conditions, cells located in the interior of the scaffolds are not able to receive 
fresh supply of nutrients and waste products start accumulating. The outcome is 
usually poorly developed constructs with necrotic cores. Hence, bioreactors are 
important in this aspect to overcome mass transport limitations. Bioreactors are also 
able to impart mechanical stimulation through the flow mediated shear stresses. In this 
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study, the perfusion bioreactor system has proven effective in maintaining cell viability 
and improving mineralized ECM production.    
 
7.3.4 Combining PEMF stimulation with flow perfusion bioreactor 
  In stage 4, the effects of combining PEMF stimulation with flow perfusion 
culture was investigated. This was something new as studies of PEMF treatment on 
bone cells in 3D cultures were rare, much less using a bioreactor system. The aim of 
this study was to test the hypothesis that combined PEMF stimulation and flow 
perfusion culture would lead to a synergistic production of mineralized ECM. 
 
 The perfusion chambers housing the constructs were placed in the centre region 
of the solenoid and cultured for 3 weeks. The control group was made up of constructs 
in bioreactors but without PEMF stimulation. The results did not see an enhancement 
in calcium deposition in the PEMF group over the control. Both groups had 
approximately the same amount of calcium by the end of the study. However, the 
effect of PEMF treatment was observed at the week one time point as the constructs in 
the exposed group had significant amount of calcium deposition, about twice of that 
formed in the control group samples. The lack of synergistic effects was probably 
because the finite number of cells residing in the construct was already stimulated by 
the flow perfusion to enhance calcium production, addition of PEMF exposure did not 
provide further stimulatory effects. 
 
 In this study, the perfusion bioreactor system served to ensure that the seeding 
distribution throughout the construct was homogeneous. A homogeneously seeded 
constructed leads to even distribution of mineralized ECM. This would increase the 
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probability of producing a more functional graft. The PEMF system did not further 
enhance the deposition of calcium in the constructs. Nevertheless, it was interesting to 
note that PEMF stimulation was able to hasten the production of calcium in the 
constructs. This implied that PEMF could be used to accelerate bone formation in 
tissue engineered constructs, thereby reducing the time required to culture a bone graft. 
 
7.4 Conclusion 
 In this study, the effects of combined mechanical and PEMF stimulation on the 
osteogenesis of MSCs were studied. This was achieved by accomplishing the specific 
objectives which investigated the effects of PEMF stimulation on the different types of 
culture systems in a progressive manner.  
 
Firstly, a PEMF stimulation apparatus was designed, built and characterized. 
Rabbit MSCs were also isolated and characterized. The MSCs were cultured in 
osteogenic medium and exposed to PEMF stimulation to study the effects of PEMF in 
a 2D culture model. It was demonstrated that PEMF stimulation was able to enhance 
the production of mineralized ECM in MSCs directed towards osteogenic lineage, 
hence proving the first hypothesis. 
 
Secondly, a silk sponge scaffold was developed and characterized to provide a 
3D environment for the culture of MSCs in osteogenic medium. The scaffold 
demonstrated its ability to maintain cell growth and development for bone tissue 
engineering. The MSCs were seeded into the scaffold to study the effects of PEMF on 
MSCs cultured in a 3D model. PEMF treatment was able to significantly enhance the 
production of mineralized ECM in the 3D model. 
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Thirdly, a perfusion bioreactor system was designed and built to overcome 
limitations with uneven seeding distribution and transportation of nutrients and wastes. 
The bioreactor system, with its dynamic seeding function, proved to produce 
constructs which had more even cell distribution. It was also able to maintain cell 
viability over extended periods and enhanced the production of mineralized matrix. 
This bioreactor system served as the final model for in vitro culture in the final stage. 
 
Finally, the PEMF system was integrated with the perfusion culture system to 
enable the study of combined stimulation. The aim of this stage was to prove the 
hypothesis that combined PEMF and mechanical stimulation would produce a 
synergistic effect in the production of calcified ECM. The findings from the study did 
not manage to prove the hypothesis. Combined stimulation did not result in enhanced 
production of calcified ECM over the control. However, one interesting finding was 
that combined stimulation significantly accelerated calcium deposition in the 
constructs. At week one of the study, a significant amount of calcium was deposited in 
the PEMF exposed group and the quantity was twice of that measured in the control 
group. Although the investigator did not manage to prove the hypothesis, the results 
implied that PEMF could be used to accelerate bone formation in tissue engineered 
constructs, thereby reducing the time required to culture a bone graft. 
 
PEMF stimulation has been approved by the FDA since 1979 as a safe and 
effective treatment for bony non-unions, congenital pseudarthrosis and failed fusion. 
Mesenchymal stem cells play an important role in the maintenance and repair of bone. 
Currently, not much work has been done on investigating the effects of PEMF 
stimulation on MSCs (related publications are less than 5). In view of the role that 
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MSCs play in bone healing, the findings in this project suggest that there is potential 




























Recommendation for Future Work 
 This study used BMSCs from the New Zealand White rabbit species as its 
cellular source. The investigator recommends using human BMSCs for future 
experiments. Firstly, the database of scientific knowledge about specific cellular 
markers for BMSCs and osteoblast cells in the New Zealand White rabbit is quite 
limited. Multipotency of the harvested cells was demonstrated only by the ability to 
differentiate into the osteogenic, chondrogenic and adipogenic lineages. On the other 
hand, there are a number of well known CD markers for human BMSCs which are 
available for the investigator to utilize. Secondly, while the genetic code of rabbits is 
presently not complete, the human genome is completely sequenced. Using human 
BMSCs in future studies would enable the study of gene expression of various proteins 
which are important in the osteogenesis process.  
 
Thirdly, the types of cells affect the cellular responses to PEMF stimulation. 
BMSCs from rabbit and human might respond to different dose or regime of PEMF 
exposure. Using human BMSCs makes it easier to translate the technology. Fourthly, 
human BMSCs are more robust than rabbit BMSCs. Human BMSCs are known to be 
highly proliferative and still display multipotency after many passages. Rabbit BMSCs 
suffer from declining proliferation and differentiation potential with increase in 
passage. Hence, rabbit BMSCs need to be used as early as possible. However, tissue 
engineering applications typically high initial seeding densities, the amount of rabbit 
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BMSCs would be quite limited compared to human BMSCs which can be expanded in 
vitro to the required numbers. 
 
The investigator recommends that an extensive optimization of PEMF 
parameters be done to study how factors like field strength, intensity and frequency 
affect the response of BMSCs to stimulation. Future studies could also investigate the 
cell signaling pathways of PEMF stimulation on BMSCs. This could be done by 
exposing the cells to PEMF treatment while using chemicals which are cell signaling 
inhibitors. Elucidating the signal transduction pathways in PEMF-stimulated 
osteogenesis of BMSCs could provide a basis for investigators to allow optimization of 
the effects of stimulation on bone growth and graft development. Besides signal 
transduction studies, future studies could also investigate the real time cellular 
response of cells during PEMF stimulation, such as cellular migration. A single cell or 
cluster of cells could be cultured in a chamber which could be mounted on a 
microscope to record real time events during stimulation. Such an approach would 
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Histology staining techniques 
 
Hematoxylin & Eosin Staining Method 
1. De-paraffin sections in xylene for 2 x 3 min OR until the wax is gone. 
Blot excess xylene before going into ethanol. 
Note: DO NOT touch the timer if there is xylene on gloves. 
2. Clear sections in ethanol 100% 1 x 3 min 
95% 1 x 3 min 
70% 1 x 3 min 
3. Wash in deionized water for 5 min. 
Blot excess water before going into hematoxylin. 
4. Stain in Mayer’s hematoxylin for 10 min OR Harris’ hematoxylin for 2 min. 
5. Rinse in water. 
6. Optional: 1 x 5 min in tap water. 
7. Optional: Dip in 1% acid alcohol for 1 second, rinse in water till water is clear.  
8. Dip in alkaline solution for a few seconds. 
9. Rinse in water. 
Blot excess water before going into eosin. 
10. Counter-stain in eosin for 2 to 3 seconds ONLY. 
11. Rinse in water. 
12. Optional: View under microscope to check staining. If unsatisfactory, de-stain 
in 1% acid alcohol. Rinse in water. 
13. Dehydrate in ethanol  70% 1 x 3 min 
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95% 1 x 3 min 
100% 1 x 3 min 
14. Clear in xylene 2 x 5 min. 
15. Mount sections in mounting medium. 
16. Allow drying before viewing. 
Results: 
Nuclei – blue to blue black (stained by hematoxylin) 
Cytoplasm – pink (stained by eosin) 
 
Von Kossa staining 
1. De-paraffin sections in xylene for 2 x 3 min OR until the wax is gone. 
2. Rinse in several changes of distilled water. 
3. Incubate sections with 1% silver nitrate solution in a clear glass coplin jar 
placed under ultraviolet light for 20 minutes. 
4. Rinse in several changes of distilled water. 
5. Remove un-reacted silver with 5% sodium thiosulfate for 5 minutes. 
6. Rinse in distilled water. 
7. Counter-stain with nuclear fast red for 5 minutes 
8. Rinse in distilled water 
9. Dehydrate through graded alcohol and clear in xylene. 
10. Coverslip using mounting medium. Wait for it to dry before viewing. 
Results: 
Calcium salts – black or brown-black 
Nuclei – red 




















Measurements for winding a solenoid 


















5 mm (acrylic ring) 
10 mm 
Acrylic tube 
ID = 70 mm 
OD = 80 mm 
330 mm (enameled copper wire, 0.85mm diameter, 4 layers) 
360 mm 
